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SUMMARY 
PART I. AN INVESTIGATION OF CHYMOTRYPSIN A y INHIBITION 
WITH PEPTIDE ALDEHYDES AND RELATED ANALOGS 
Three peptide aldehydes and related analogs were synthesized 
and tested for their ability to generate models of the tetrahedral 
transition state for chymotrypsin-catalyzed substrate hydrolysis. 
Competitive inhibition experiments with chymotrypsin A^ show that 
N-benzyloxycarbonylphenylalaninal (Z-Phe-H) was the most effective 
inhibitor, binding about 400-fold more tightly than comparable amide 
substrates. Two naphthalene aldehydes were also found to effectively 
inhibit A^, but significant spectral perturbations were not observed 
when either chromophoric aldehyde was complexed with the enzyme. X-ray 
crystallographic studies, however, suggest that Z-Phe-H and the dipep-
tide aldehyde Ac-Ala-Phe-H inhibit chymotrypsin A^ crystals without 
altering unit cell dimensions. Semicarbazone derivatives of our pep­
tide aldehydes were seen to be slightly less reactive than the corre­
sponding aldehydes; peptide alcohols were unreactive. On the basis of 
these kinetic results, together with data from other investigators, we 
suggest that our aldehydes reversibly bind to chymotrypsin as covalent 
tetrahedral hemiacetals, and that these enzyme-aldehyde complexes are 
stereochemical^ analogous to the tetrahedral transition state for the 
hydrolysis reaction. 
ix 
PART II. INHIBITION OF ELASTASE BY 
TETRAPEPTIDE CHLOROMETHYL KETONES 
Tetrapeptide chloromethyl ketones containing valine, isoleucine 
and threonine as the P^ residues were synthesized as active-site directed 
irreversible inhibitors of elastase. Based on relative k , ,/[I] values, 
obsd 
the P^-valine and isoleucine chloromethyl ketones were observed to be 
reactive and specific inhibitors for both porcine pancreatic elastase 
and human leukocyte elastase. The analogous threonine chloromethyl 
ketone was relatively unreactive. Trypsin and chymotrypsin which are 
closely related to elastase were not significantly inhibited by our 
tetrapeptide chloromethyl ketones. With porcine pancreatic elastase, 
the valine and isoleucine chloromethyl ketone inhibitors were as 
effective or slightly more effective than our standard P^-alanine tetra­
peptide inhibitor. With human leukocyte elastase, on the other hand, the 
valine and isoleucine inhibitors were markedly more effective than the 
alanine ketone (the best one being Ac-Ala-Ala-Pro-Val-CH^Cl). These 
results imply that the two elastolytic enzymes are different and dis­
tinct. Human leukocyte elastase is now implicated in the pathology of 
pulmonary emphysema and related inflammatory diseases. Eventually 
chloromethyl ketone inhibitors may become valuable in treating these 
diseases. 
PART I 
AN INVESTIGATION OF CHYMOTRYPSIN A y INHIBITION 
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o r p r o t e i n - c l e a v i n g e n z y m e s , a r e c e r t a i n l y t h e m o s t w e l l - k n o w n a n d i n t e n ­
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A c o m p r e h e n s i v e m e c h a n i s m f o r c h y m o t r y p s i n a c t i o n ( e q . 1 ) , w h o s e 
v a r i o u s f e a t u r e s h a v e b e e n e x t e n s i v e l y s t u d i e d , i s s c h e m a t i c a l l y d e p i c t e d 
i n F i g u r e 1 . ES i s t h e n o n c o v a l e n t 
c e d e s f o r m a t i o n o f t h e c o v a l e n t a c y l - e n z y m e , E S ' . P^ r e p r e s e n t s t h e i n i ­
t i a l l y r e l e a s e d a m i n e o f a n a m i d e s u b s t r a t e , a n d E S 1 i s a s e c o n d t e t r a -
t e t 
h e d r a l i n t e r m e d i a t e p r e c e d i n g t h e r e g e n e r a t i o n o f f r e e e n z y m e a n d P 9 , t h e 
P 
( 1 ) 
M i c h a e l i s c o m p l e x , a n d ES 
T e t 
i s a t e t r a h e d r a l i n t e r m e d i a t e w h i c h p r e -
F i g u r e 1. A P o s s i b l e Mechanism o f A c t i o n f o r C h y m o t r y p s i n . N o t e : From Z e f f r e n and H a l l , 1973. 
6 
c a r b o x y l i c a c i d m o i e t y . T h e i n c l u s i o n of t h e t w o t e t r a h e d r a l i n t e r m e d i ­
a t e s i n t h i s c a t a l y t i c m e c h a n i s m h a s b e e n j u s t i f i e d o n s e v e r a l g r o u n d s 
( Z e f f r e n a n d H a l l , 1 9 7 3 ; H e s s , 1 9 7 1 ; J e n c k s , 1 9 6 9 ) . D i r e c t k i n e t i c e v i ­
d e n c e f o r t e t r a h e d r a l i n t e r m e d i a t e f o r m a t i o n , h o w e v e r , h a s b e e n s u p p l i e d 
b y H e s s ejt a l . , ( 1 9 7 0 ) . B y e m p l o y i n g t e m p e r a t u r e j u m p a n d s t o p p e d - f l o w 
k i n e t i c t e c h n i q u e s , t h e d i r e c t o b s e r v a t i o n o f t w o d i s t i n c t c h y m o t r y p s i n -
s u b s t r a t e c o m p l e x e s p r i o r t o t h e f o r m a t i o n o f t h e a c y l e n z y m e a n d r e l e a s e 
o f w e r e m a d e p o s s i b l e . T h e s e i n t e r m e d i a t e s w e r e t h o u g h t t o b e t h e 
M i c h a e l i s c o m p l e x a n d a t e t r a h e d r a l c o m p l e x . R e c e n t l y , c r y s t a l l o g r a p h i c 
o b s e r v a t i o n s o f t e t r a h e d r a l a d d u c t s h a v e b e e n m a d e i n t h e b o v i n e t r y p s i n -
b a s i c p a n c r e a t i c t r y p s i n i n h i b i t o r c o m p l e x ( R u h l m a n e t ^ a l . , 1 9 7 3 ) , i n t h e 
p o r c i n e t r y p s i n - s o y b e a n t r y p s i n i n h i b i t o r c o m p l e x ( S w e e t ejt a l . , 1 9 7 4 ) , 
a n d b e t w e e n a r o m a t i c b o r o n i c a c i d s a n d s u b t i l i s i n ( M a t t h e w s e t ^ a l . , 1 9 7 5 ) . 
I n t h e c a s e w h e r e t h e h o m o l o g o u s c h y m o t r y p s i n p r o t e a s e , t r y p s i n , w a s 
c o m p l e x e d w i t h t h e l a r g e p a n c r e a t i c t r y p s i n i n h i b i t o r ( F i g u r e 2 ) , t h e 
0 ^ a t o m o f t r y p s i n ' s S e r - 1 9 5 w a s f o u n d t o b e c o v a l e n t l y l i n k e d t o t h e 
carbonyl carbon of L y s - 1 5 of the inhibitor. The n e g a t i v e l y charged o x y ­
g e n a t t h e t e t r a h e d r a l c a r b o n , m o r e o v e r , w a s h y d r o g e n b o n d e d t o t h e a m i d e 
n i t r o g e n s of G l y - 1 9 3 a n d S e r - 1 9 5 o f t r y p s i n . 
A g r e a t d e a l o f i n f o r m a t i o n a b o u t b i n d i n g s p e c i f i c i t y h a s b e e n 
o b t a i n e d f r o m c r y s t a l l o g r a p h i c i n v e s t i g a t i o n s o f c h y m o t r y p s i n c o m p l e x e d 
w i t h s m a l l m o l e c u l e s . F o r e x a m p l e , c a l c u l a t e d e l e c t r o n d e n s i t y m a p s 
s h o w e d q u i t e c l e a r l y t h a t c h y m o t r y p s i n ' s p r i m a r y s p e c i f i c i t y s i t e w a s a 
o 
h y d r o p h o b i c d e p r e s s i o n o r p o c k e t a b o u t 1 2 x 6 . 5 x 4 A i n s i z e o n t h e 
e n z y m e s u r f a c e a n d i n t o w h i c h t h e a r o m a t i c s i d e c h a i n o f s u b s t r a t e s o r 
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H i s 57 
A s p 1 0 2 
H — N 








P 2 ~ 
H — N - G l n 1 9 2 
H 
S e r 2 1 4 
i 
N —H 
T r p 2 1 5 
C = 0 
H N 
I 
G l y 216 I 
0 = C 
\ 
S e r 217 
F i g u r e 2 . A n I l l u s t r a t i o n o f t h e B i n d i n g I n t e r a c t i o n s B e t w e e n 
T r y p s i n a n d t h e P a n c r e a t i c T r y p s i n I n h i b i t o r . 
N o t e : F r o m L i l l j a s a n d R o s s m a n n , 1 9 7 4 . 
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inhibitors could fit snugly (Steitz et̂  al., 1969). Even though these 
and other binding interactions have been studied, little detailed 
information has been revealed concerning the structural and conformational 
changes that take place during chymotrypsin catalysis. This situation 
provides the incentive for the development of a structural model of the 
enzyme-substrate complex preceding acyl enzyme formation. As previously 
implied, it is generally supposed that this complex may be a highly 
activated tetrahedral intermediate which resembles a transition state 
for the hydrolysis reaction. 
This thesis, Part I, reports our approach toward studying this 
important tetrahedral enzyme-substrate complex. The substrate analogs 
chosen for study are peptide aldehydes and related compounds. Their 
synthesis as well as their kinetics, ultraviolet, and crystallographic 
behavior are described. In addition, some explanations and implications 
of the data are considered. 
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CHAPTER I I 
EXPERIMENTAL 
M a t e r i a l s and M e t h o d s 
C h y m o t r y p s i n A ( l o t 5 3 C - 8 1 3 0 ) and s u b t i l i s i n B P N 1 ( l o t 1 0 2 C - 0 6 5 0 ) 
were p u r c h a s e d f rom S igma C h e m i c a l C o . and u s e d w i t h o u t f u r t h e r p u r i f i c a ­
t i o n i n the k i n e t i c s t u d i e s ; t h e i r s u b s t r a t e , N - a c e t y l - L - t y r o s i n e e t h y l 
e s t e r ( A c - T y r - O E t ) , was s y n t h e s i z e d i n o u r l a b o r a t o r y and had mp 8 0 - 8 1 ° . 
C h y m o t r y p s i n o g e n A ( l o t 1 1 1 C - 8 1 7 0 ) and a c e t y l - t r y p s i n ( l o t 9 0 C - 2 2 0 0 ) were 
a l s o o b t a i n e d f rom S igma C h e m i c a l C o . and u s e d w i t h o u t f u r t h e r p u r i f i c a ­
t i o n . D i a f l o u l t r a f i l t e r s u s e d i n enzyme c o n c e n t r a t i o n were p u r c h a s e d 
f rom Amicon C o r p . C a r b o x y m e t h y l c e l l u l o s e , CM-52 m i c r o g r a n u l a r , was p u r ­
c h a s e d f rom Whatman B i o c h e m i c a l s L t d . Sephadex G-25 f i n e was o b t a i n e d 
f rom P h a r m a c i a F i n e C h e m i c a l s . 
N - B e n z y l o x y c a r b o n y l - L - p h e n y l a l a n i n e c h l o r o m e t h y l k e t o n e (Z-Phe-CH^Cl) 
was p r e p a r e d f rom Z - P h e C I O ^ by the method o f Shaw ( 1 9 6 7 ) . AgF and N,N - c a r -
b o n y l d i i m i d a z o l e were p u r c h a s e d f rom PCR. N - m e t h y l a n i l i n e was o b t a i n e d 
f rom Eas tman O r g a n i c C h e m i c a l s and r e d i s t i l l e d b e f o r e u s e ( B . P . 3 9 ° / 3 0 0 ] j ) . 
2 - n a p h t h a l d e h y d e was p u r c h a s e d f rom A l d r i c h C h e m i c a l C o . , I n c . ; 1 - n a p h t h -
a l d e h y d e was o b t a i n e d f rom Eas tman O r g a n i c C h e m i c a l s . O p t i c a l l y a c t i v e 
amino a c i d s were o b t a i n e d f rom commerc ia l s o u r c e s . A l l o t h e r r e a g e n t s 
and s o l v e n t s were a n a l y t i c a l g r a d e . 
M a s s s p e c t r a were t a k e n on a P e r k i n - E l m e r H i t a c h i RMU-7L i n s t r u m e n t , 
and n u c l e a r m a g n e t i c r e s o n a n c e (nmr) s p e c t r a were t a k e n on V a r i a n A - 6 0 o r 
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T - 6 0 i n s t r u m e n t s . Enzyme i n h i b i t i o n k i n e t i c s w e r e p e r f o r m e d o n a 
R a d i o m e t e r a u t o m a t e d p H - s t a t s y s t e m ( m o d e l TTT 1 1 ) . U l t r a v i o l e t a b s o r p ­
t i o n s t u d i e s w e r e p e r f o r m e d o n a Beckman M o d e l - 2 5 s p e c t r o p h o t o m e t e r . 
X - r a y p r e c e s s i o n p h o t o g r a p h s w e r e t a k e n o n a B u e r g e r P r e c e s s i o n C a m e r a 
( M o d e l 3 0 0 0 ) s u p p l i e d b y S u p p e r C o . I n t e g r a t e d i n t e n s i t i e s w e r e m e a s u r e d 
f r o m d i f f r a c t i o n p h o t o g r a p h s b y m e a n s o f a n a u t o m a t e d S y n t e x m i c r o d e n s i -
t o m e t e r . 
D i h y d r o - 4 - B e n z y l - 2 H - l , 3 - O x a z i n e - 2 , 5 ( 3 H ) - D i o n e 
N - b e n z y l o x y c a r b o n y l - L - p h e n y l a l a n i n e d i a z o k e t o n e ( 1 . 5 g m , 4 . 6 m m o l ) , 
p r e p a r e d f r o m Z - P h e - O H a n d d i a z o m e t h a n e u s i n g a m i x e d a n h y d r i d e m e t h o d 
( P e n k e e t a l , 1 9 7 0 ) , w a s d i s s o l v e d i n a n i s o l e ( 5 0 m l ) a n d t h e n a d d e d t o a 
10% e t h e r e a l s o l u t i o n o f l i q u i d a n h y d r o u s HF ( 3 . 0 g m , 15 m m o l ) i n a p o l y ­
e t h y l e n e b o t t l e a t 0 ° C . S t i r r i n g w a s c o n t i n u e d a t r o o m t e m p e r a t u r e u n t i l 
t h e r e a c t i o n w a s c o m p l e t e a s i n d i c a t e d b y t h i n - l a y e r c h r o m a t o g r a p h y . 
W o r k - u p o f t h e m i x t u r e i n v o l v e d e v a p o r a t i o n o f t h e s o l v e n t i n v a c u o , 
e x t r a c t i o n o f t h e r e s i d u e i n t o e t h y l a c e t a t e , w a s h i n g w i t h c i t r i c a c i d a n d 
NaHCO^ s o l u t i o n s , d r y i n g o v e r a n h y d r o u s m a g n e s i u m s u l f a t e a n d e v a p o r a t i o n 
t o a y e l l o w o i l . T h e r e s i d u e w a s t h e n d i s s o l v e d i n c h l o r o f o r m a n d c h r o m a -
t o g r a p h e d o n M e r c k s i l i c a g e l G 0 . 0 6 3 - 0 . 2 mm. The p r o d u c t w a s i s o l a t e d 
a f t e r e l u t i o n w i t h 2% m e t h a n o l i n c h l o r o f o r m . R e c r y s t a l l i z a t i o n f r o m 
e t h y l a c e t a t e - c y c l o h e x a n e g a v e 0 .48 gm (51%) o f a w h i t e s o l i d , mp 1 3 5 - 1 3 6 ° , 
R f . 2 8 ( C H C 1 3 - C H 3 0 H , 9 : 1 ) . 
T h e n m r s p e c t r u m s h o w e d p e a k s a t 6 7 . 3 0 ( 5 H , s , P h ) , 
5 . 8 1 ( 1 H , b , N H ) , 4 . 5 3 ( 2 H , d , P h C H 2 0 ) , 4 . 1 1 ( 1 H , m , NHCHCO), 3 . 0 5 ( 2 H , 
c o m p l e x , C H ( C H - ) P h ) . T h e mass s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 
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205CM+, 4 5 . 8 % ) , 1 6 1 ( M - C 0 2 + , 1 6 . 7 % ) , 1 1 8 ( N H = C ( C H 2 O H ) + , 8 3 . 7 % ) a n d 
9 1 ( C 7 H 7 + , b a s e p e a k ) . 
A n a l . C a l c d f o r C 1 1 H 1 1 N 0 3 : c » 6 4 . 3 9 ; H , 5 . 3 6 ; N , 6 . 8 1 . 
F o u n d : C, 6 4 . 4 9 ; H , 5 . 2 2 ; N , 6 . 6 1 . 
N - B e n z y l o x y c a r b o n y l - L - P h e n y l a l a n i n e H y d r o x y m e t h y I k e t o n e (Z-Phe-CHpOH) 
N - B e n z y l o x y c a r b o n y l - L - p h e n y l a l a n i n e i o d o m e t h y l k e t o n e 
w a s p r e p a r e d b y i o d i n a t i o n o f Z - P h e - C H ^ C l w i t h s o d i u m i o d i d e i n a c e t o n e . 
To a s o l u t i o n o f Z - P h e - C H 2 I ( 5 . 0 g m , 1 1 . 8 m m o l ) i n a c e t o n i t r i l e ( 1 0 0 m l ) 
w a s a d d e d a s o l u t i o n o f A g F ( 4 g m , 32 m m o l ) i n w a t e r ( 5 m l ) . A f t e r s t i r ­
r i n g f o r 30 m i n u t e s a t 5 0 ° , t h e m i x t u r e w a s f i l t e r e d a n d e x t r a c t e d 
w i t h e t h y l a c e t a t e ( 2 x 50 m l ) . T h e o r g a n i c e x t r a c t s w e r e d r i e d o v e r 
m a g n e s i u m s u l f a t e a n d c o n c e n t r a t e d i n v a c u o t o a n o i l . A s o l u t i o n o f 
t h i s o i l i n c h l o r o f o r m w a s t h e n c h r o m a t o g r a p h e d o n s i l i c a g e l ( 6 0 g m ) . 
T h e c r y s t a l l i n e p r o d u c t w a s i s o l a t e d a f t e r e l u t i o n w i t h m e t h a n o l - c h l o r o -
f o r m ( 1 : 1 0 0 ) . R e c r y s t a l l i z a t i o n f r o m e t h y l a c e t a t e - c y c l o h e x a n e g a v e 
1 . 8 gm (48%) o f a w h i t e s o l i d , mp 8 8 - 8 9 ° , R f . 4 1 ( C H C ^ - C l ^ O H , 1 : 2 4 ) , 
i r ( C H C l 3 ) , 1 7 1 7 c m _ 1 ( c = 0 ) . The n m r s p e c t r u m ( C D C l ^ ) s h o w e d p e a k s a t 
6 7 . 3 6 ( 1 0 H , m , P h ) , 7 . 0 5 ( 1 H , m , N H ) , 5 . 1 0 ( 2 H , s , P h C H ^ O ) , 5 . 2 8 ( 1 H , b , C H ^ H ) , 
4 . 6 0 ( 1 H , m , NHCHCO), 4 . 1 8 ( 2 H , s , CH^OH) , 3 . 0 6 ( 2 H , d , P h C H ^ C H ) . The n m r 
s p e c t r u m (DMSO) s h o w e d t h e h y d r o x y l p r o t o n p e a k a t 5 . 3 5 ( 1 H , t , C H ^ H , 
w h i c h d i s a p p e a r e d u p o n a d d i n g n 2 0 ) . A s i n g l e t i n s t e a d o f a t r i p l e t 
a p p e a r e d i n t h e d o u b l e r e s o n a n c e s p e c t r u m (DMSO) o f t h i s c o m p o u n d , i n d i ­
c a t i n g t h a t t h e s p i n - s p i n c o u p l i n g b e t w e e n t h e m e t h y l e n e a n d h y d r o x y l 
h y d r o g e n s h a d b e e n d e s t r o y e d w h e n t h e m e t h y l e n e h y d r o g e n s w e r e i r r a d i a t e d . 
T h e mass s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 3 1 3 ( M + , . 1 6 % ) , 
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2 8 2 ( P h C H 2 0 C O N H C H ( C H 2 P h ) C O + , 1 . 1 % ) , 2 5 4 ( P h C H 2 0 C 0 N H C H ( C H 2 P h ) + , b a s e p e a k ) , 
2 1 0 ( P h C H 2 N H = C H C H 2 P h + , 7 3 . 7 % ) , 9 1 ( C ? H + , 7 8 . 9 % ) . 
A n a l . C a l c d f o r C 1 o H i n N 0 . : C , 6 8 . 9 8 ; H , 6 . 1 1 ; N , 4 . 4 7 . 
F o u n d : C , 6 8 . 8 7 ; H , 6 . 1 4 ; N , 4 . 4 2 . 
N - B e n z y l o x y c a r b o n y l - L - P h e n y l a l a n i n a l ( Z - P h e - H ) w a s p r e p a r e d u s i n g 
m e t h o d s d e v e l o p e d b y J a p a n e s e w o r k e r s ( S a e k i e t a l . , 1 9 7 3 ; S h i m i z u e t a l . , 
1 9 7 2 ; I t o e t a l . , 1 9 7 2 ) . N - b e n z y l o x y c a r b o n y l - L - p h e n y l a l a n i n e ( 4 . 5 g m , 
15 mmol ) w a s d i s s o l v e d i n d r y t e t r a h y d r o f u r a n a n d c o o l e d t o 1 0 ° i n a 
t h r e e - n e c k e d f l a s k e q u i p p e d w i t h d r y i n g t u b e , t h e r m o m e t e r , r u b b e r s e p ­
t u m a n d m a g n e t i c s t i r r e r . N , N - c a r b o n y l d i i m i d a z o l e ( 2 . 7 g m , 1 6 . 8 m m o l ) w a s 
a d d e d a n d t h e r e s u l t i n g p a l e y e l l o w s o l u t i o n s t i r r e d f o r 15 m i n u t e s . 
A f t e r c o o l i n g t h e r e a c t i o n m i x t u r e t o - 1 5 ° i n e t h y l e n e g l y c o l / d r y i c e , 
. 7 8 8 M l i t h i u m a l u m i n u m h y d r i d e i n t e t r a h y d r o f u r a n ( 2 8 . 5 m l , 2 2 . 5 m m o l ) 
w a s s l o w l y a d d e d d r o p w i s e . S t i r r i n g w a s c o n t i n u e d a n a d d i t i o n a l 45 m i n ­
u t e s a t - 1 5 ° . E x c e s s L i A l H ^ w a s t h e n d e s t r o y e d b y s l o w l y a d d i n g d r o p w i s e 
30 m l o f i c e c o l d 1 M N H . C 1 . T h e r e a c t i o n m i x t u r e w a s f i l t e r e d a n d t h e 
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p r e c i p i t a t e s w a s h e d w i t h b o i l i n g e t h y l a c e t a t e ( 3 x 50 m l ) t o r e m o v e a n y 
o c c l u d e d o r g a n i c p r o d u c t . A f t e r e v a p o r a t i o n o f t h e t e t r a h y d r o f u r a n , t h e 
r e s i d u e w a s s u s p e n d e d i n e t h y l a c e t a t e . T h e c o m b i n e d e t h y l a c e t a t e 
e x t r a c t s w e r e d r i e d o v e r a n h y d r o u s m a g n e s i u m s u l f a t e a n d e v a p o r a t e d t o 
g i v e a c r u d e p a l e y e l l o w o i l . 
T h i s o i l w a s d i s s o l v e d i n c h l o r o f o r m a n d c h r o m a t o g r a p h e d o n 
M e r c k s i l i c a g e l G 0 . 0 6 3 - 0 . 2 mm. T h e p r o d u c t w h i c h e l u t e d w i t h c h l o r -
o f o r m - m e t h a n o l ( 6 5 : 1 ) w a s r e c r y s t a l l i z e d f r o m e t h y l a c e t a t e - c y c l o h e x a n e 
t o g i v e a w h i t e c r y s t a l l i n e s o l i d ( 1 . 3 g m , 3 0 % ) , mp 7 8 - 7 9 ° , 
1 3 
R f . 7 3 ( C H C 1 3 - C H 3 0 H , 1 9 : 1 ) , i r ( C H C l 3 ) , 1 7 2 0 c m ( C = 0 ) . T h e n m r s p e c t r u m 
( C D C 1 3 ) s h o w e d p e a k s a t 6 9 . 7 5 ( 1 H , s , C H O ) , 7 . 4 7 ( 1 0 H , m , P h ) , 5 . 1 7 ( 2 H , 
s , P h C H ^ O ) , 4 . 5 2 ( 1 H , m , N H C H C O ) , 3 . 1 4 ( 2 H , d , C H C H ^ P h ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 2 8 3 ( M + , . 1 3 % ) , 
2 5 4 ( ( M - C H O ) + , 2 2 % ) , 2 1 0 ( P h C H 2 C H C H C H 2 P h + , 1 4 % ) , 1 6 4 ( P h C H 2 0 C 0 N H C H 2 + , 5 . 3 % ) 
9 1 ( C 7 H 7 + , b a s e p e a k ) . 
F u r t h e r e l u t i o n w i t h c h l o r o f o r m - m e t h a n o l ( 2 4 : 1 ) g a v e a s e c o n d 
c r y s t a l l i n e p r o d u c t , N - b e n z y l o x y c a r b o n y l - L - p h e n y l a l a n i n o l . R e c r y s t a l l i -
z a t i o n f r o m e t h y l a c e t a t e - c y c l o h e x a n e g a v e 0 . 8 g m ( 1 9 % ) o f a w h i t e s o l i d , 
m p 9 4 - 9 4 . 5 ° , R f . 5 1 ( C H C 1 3 - C H 3 0 H , 1 9 : 1 ) . 
T h e n m r s p e c t r u m ( C D C 1 3 ) s h o w e d p e a k s a t 6 7 . 3 0 ( 1 0 H , d , P h ) , 5 . 1 8 
1 H , b , N H ) , 5 . 0 7 ( 2 H , s , P h C H ^ O ) , 3 . 8 9 ( 1 H , m , N H C H ) , 3 . 6 1 ( 2 H , m , C H C H ^ O H ) , 
2 . 8 4 ( 2 H , d , C H C H ^ P h ) , 2 . 3 1 ( 1 H , s , C H 2 0 H , w h i c h d i s a p p e a r e d u p o n a d d i n g 
D 2 0 ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 2 8 5 ( 1 ^ * " , . 1 5 % ) , 
2 5 4 ( ( M - C H 2 O H ) + , 1 . 4 % ) , 2 1 0 ( P h C H 2 N H C H C H 2 P h + , 1 . 4 % ) , 1 9 4 ( ( M - C ^ ) * , 1 1 . 6 % ) , 
1 5 0 ( P h C H 2 C H ( N H ) C H 2 O H + , 4.8%), 9 1 ( 0 ^ + , b a s e p e a k ) . 
A n a l . C a l c d f o r C 1 _ H 1 Q N 0 _ : C , 7 1 . 5 8 ; H , 6 . 6 7 ; N , 4 . 9 1 . 
F o u n d : C , 7 1 . 6 0 ; H , 6 . 7 4 ; N , 4 . 8 9 
N - B e n z y l o x y c a r b o n y l - L - P h e n y l a l a n i n a l S e m i c a r b a z o n e 
T o t h e c r u d e o i l o f N - b e n z y l o x y c a r b o n y l p h e n y l a l a n i n a l w a s i m m e ­
d i a t e l y a d d e d a s o l u t i o n o f s e m i c a r b a z i d e h y d r o c h l o r i d e ( 4 . 5 g ) a n d 
s o d i u m a c e t a t e ( 7 . 8 g m ) i n w a t e r ( 5 0 m l ) . T h e m i x t u r e w a s s h a k e n v i g o r ­
o u s l y , w a r m e d o n a s t e a m b a t h f o r 1 5 m i n u t e s , t r e a t e d w i t h 9 5 % e t h a n o l 
u n t i l t u r b i d i t y j u s t d i s a p p e a r e d , a n d t h e n p l a c e d i n t h e r e f r i g e r a t o r 
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o v e r n i g h t . T h e r e a c t i o n m i x t u r e w a s d i l u t e d w i t h a s m a l l a m o u n t o f 
w a t e r t o s e p a r a t e a n o i l . T h e s o l v e n t w a s d e c a n t e d a n d t h e r e s i d u a l 
o i l d i s s o l v e d i n e t h a n o l a n d f i l t e r e d . T h e f i l t r a t e w a s c o o l e d i n a n 
i c e b a t h a n d w a t e r g r a d u a l l y a d d e d u n t i l t u r b i d i t y . T h e m i x t u r e w a s 
a l l o w e d t o s t a n d f o r s e v e r a l d a y s i n t h e r e f r i g e r a t o r . A c r y s t a l l i n e 
p r o d u c t w a s i s o l a t e d a n d r e c r y s t a l l i z e d f r o m e t h y l a c e t a t e - c y c l o h e x a n e -
raethanol t o g i v e 1 . 8 gm (43%) o f a w h i t e s o l i d , mp 1 3 0 - 1 3 1 ° , 
R f 0 . 7 4 ( C H C 1 3 - C H 3 0 H , 4 : 1 ) . 
The n m r s p e c t r u m ( C D C 1 3 ) s h o w e d p e a k s a t 6 9 . 6 6 ( 1 H , s , CH=NNH) , 
7 . 3 6 ( 1 0 H , d , P h ) , 7 . 0 7 ( 1 E , d , CHCHNNH), 6 . 1 8 ( 1 H , b , CQNHCH), 5.68 ( 2 H , 
b , C 0 N H 2 ) , 5 . 0 4 ( 2 H , s , P h C H ^ O ) , 4 . 5 6 ( 1 H , m , N H C H C h ^ P h ) , 2 . 9 5 ( 2 H , d , C H C H ^ P h ) . 
T h e mass s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 3 4 0 ( M + , . 6 % ) , 
2 8 2 ( P h C H 2 O C O N H C H ( C H 2 P h ) C H = N H + , 4 . 8 % ) , 189 ( P h C H 2 C H C N N H C O N H 2 + , 1 1 . 4 % ) , 
1 5 0 ( P h C H 2 0 C O N H + , 1 4 % ) , 1 0 8 ( P h C H 2 O H + , 3 3 % ) , 9 1 ( 0 ^ + , b a s e p e a k ) . 
A n a l . C a l c d f o r C 1 o H _ _ N . 0 o : C , 6 3 . 5 3 ; H , 5 . 8 8 ; N , 1 6 . 4 7 
lo zU 4 J 
F o u n d : C, 6 3 . 5 8 ; H , 5 . 9 6 ; N , 1 6 . 4 2 . 
F o r m y l - L - P h e n y l a l a n i n e ( C H O - P h e - O H ) 
F o r m y l - L - p h e n y l a l a n i n e w a s p r e p a r e d b y t h e p e p t i d e c o u p l i n g 
m e t h o d o f d u V i g n e a u d e_t a l . ( 1 9 3 2 ) . To a m i x t u r e o f L - p h e n y l a l a n i n e 
( 4 9 . 5 g m , 0.30 m o l e ) i n r e f l u x i n g 97% f o r m i c a c i d ( 1 6 0 m l ) w a s a d d e d 
d r o p w i s e a c e t i c a n h y d r i d e ( 2 9 . 1 m l , 0.28 m m o l ) . T h e r e a c t i o n m i x t u r e w a s 
s t i r r e d f o r 5 m i n u t e s a n d t h e n q u e n c h e d w i t h 90 m l o f i c e w a t e r . E v a p o ­
r a t i o n o f t h e m i x t u r e i n v a c u o g a v e a c r y s t a l l i n e p r o d u c t w h i c h w a s 
r e c r y s t a l l i z e d f r o m h o t w a t e r t o g i v e 5 1 gm (88%) o f a w h i t e s o l i d , 
mp 1 7 1 - 1 7 2 ° . L i t : mp 1 6 8 ° ( F i s h e r a n d S c h o e l l e r , 1 9 0 7 ) . 
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F o r m y l - L - P h e n y l a l a n l n a l ( C H Q - P h e - H ) 
To a s o l u t i o n o f f o r m y l - L - p h e n y l a l a n i n e ( 3 . 9 g m , 20 m m o l ) i n 
a n h y d r o u s t e t r a h y d r o f u r a n ( 1 5 0 m l ) w a s a d d e d N , N - c a r b o n y l d i i m i d a z o l e 
( 3 . 6 g , 2 2 . 2 m m o l ) . T h e c o l o r l e s s s o l u t i o n w a s s t i r r e d a t 1 5 ° f o r 1 0 
m i n u t e s a n d t h e n c o o l e d t o - 1 5 ° . 1 . 1 5 M l i t h i u m a l u m i n u m h y d r i d e i n 
t e t r a h y d r o f u r a n ( 2 6 m l , 30 m m o l ) w a s s u b s e q u e n t l y a d d e d d r o p w i s e o v e r a 
15 m i n u t e p e r i o d ; e x c e s s r e a g e n t w a s d e s t r o y e d b y a d d i t i o n o f i c e c o l d 
1 M N H ^ C l ( 5 0 m l ) . A f t e r e v a p o r a t i o n o f t h e t e t r a h y d r o f u r a n u n d e r N ^ , 
t h e r e s i d u e w a s s u s p e n d e d i n e t h y l a c e t a t e . T h e p r e c i p i t a t e s w e r e t h e n 
q u i c k l y f i l t e r e d a n d w a s h e d w i t h s o l v e n t t o r e m o v e o c c l u d e d o r g a n i c p r o ­
d u c t s . The e t h y l a c e t a t e e x t r a c t s w e r e c o m b i n e d , d r i e d o v e r a n h y d r o u s 
m a g n e s i u m s u l f a t e , a n d e v a p o r a t e d t o a c o l o r l e s s o i l . T h i s c r u d e o i l 
r a p i d l y d e c o m p o s e s a n d y e l l o w s u n l e s s s t o r e d i m m e d i a t e l y u n d e r n i t r o g e n 
i n t h e f r e e z e r . 
I s o l a t i o n o f p u r e a l d e h y d e i n v o l v e d s e v e r a l p u r i f i c a t i o n s t e p s . 
T h e c r u d e o i l w a s d i s s o l v e d i n c h l o r o f o r m a n d c h r o m a t o g r a p h e d o n M e r c k 
s i l i c a g e l G , 0 . 0 6 3 - 0 . 2 mm. E l u t i o n w i t h c h l o r o f o r m - m e t h a n o l ( 1 9 : 1 ) 
g a v e a l d e h y d e - c o n t a i n i n g f r a c t i o n s w h i c h w e r e t h e n p o o l e d a n d e v a p o r a t e d . 
F u r t h e r s e p a r a t i o n o f t h e a l d e h y d e f r o m t r a c e s o f i m i d a z o l e was 
e f f e c t e d b y m e a n s o f l i q u i d c h r o m a t o g r a p h y u s i n g a 6 ' x 3 / 4 " s i l i c a W o e l m 
c o l u m n a n d a c h l o r o f o r m - m e t h a n o l s o l v e n t s y s t e m ( 1 9 : 1 ) . A l d e h y d e f r a c ­
t i o n s w e r e p o o l e d , e v a p o r a t e d t o a s m a l l v o l u m e ( 1 o r 2 m l ) a n d t r a n s ­
f e r r e d t o a H i c k m a n s t i l l . A f t e r t h e c o m p l e t e r e m o v a l o f o r g a n i c s o l ­
v e n t s , t h e p a l e y e l l o w o i l w a s d i s t i l l e d ( 1 6 0 - 1 9 0 ° , 4 0 0 y ) t o g i v e a v i s ­
c o u s , c o l o r l e s s o i l w h i c h c r y s t a l l i z e d o n c o o l i n g . R e c r y s t a l l i z a t i o n f r o m 
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e t h y l a c e t a t e - c y c l o h e x a n e g a v e a w h i t e s o l i d ( . 4 g m , 1 2 % ) , mp 6 5 - 7 0 ° , 
R f . 4 7 ( C H C 1 3 - C H 3 0 H , 9 . 1 ) , i r ( n e a t ) 1 7 2 8 c m " " 1 ( O 0 ) . 
T h e n m r ( C D C 1 3 ) s h o w e d p e a k s a t 6 9 . 5 6 ( 1 H , s , CHO) , 8 . 2 3 ( 1 H , s , 
HCONH) , 7 . 2 8 ( 5 H , s , P h ) , 7 . 1 9 ( 1 H , b , CONH) , 4 . 7 5 ( 1 H , q , N H C H ) , 
3 . 1 4 ( 2 H , d , C H 2 P h ) . 
The m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 1 7 7 ( M + , 2 . 9 % ) , 
1 5 9 ( ( M - H 2 0 ) + , 7 . 0 % ) , 1 4 8 ( ( M - C H 0 ) + , 1 9 . 3 % ) , 1 3 2 ( P h C H 2 C H C H 0 + , 2 4 . 0 % ) , 
1 2 0 ( P h C H 2 C H N H 2 + , 3 2 . 1 % ) , 9 1 ( 0 ^ + , b a s e p e a k ) . T h e mass o f t h e m / e 
177 p e a k (M+) w a s e x a c t l y m e a s u r e d a t 1 7 7 . 0 7 8 1 ( 1 7 7 . 0 7 8 9 c a l c u l a t e d f o r 
C 1 0 H n N 0 2 ) . 
F o r m y l - L - P h e n y l a l a n i n a l S e m i c a r b a z o n e 
To t h e c r u d e o i l o f f o r m y l p h e n y l a l a n i n a l w a s i m m e d i a t e l y a d d e d a 
s o l u t i o n o f s e m i c a r b a z i d e h y d r o c h l o r i d e ( 4 gm) a n d s o d i u m a c e t a t e ( 6 gm) 
i n w a t e r ( 4 0 m l ) a n d s h a k e n v i g o r o u s l y . T h e m i x t u r e was t r e a t e d w i t h 
95% e t h a n o l u n t i l t u r b i d i t y d i s a p p e a r e d a n d t h e n a l l o w e d t o s t a n d a t 0 - 5 ° 
o v e r n i g h t . T h e s e m i c a r b a z o n e d e r i v a t i v e w h i c h s e p a r a t e d f r o m t h e s o l u ­
t i o n w a s r e c r y s t a l l i z e d f r o m w a t e r , a f f o r d i n g w h i t e n e e d l e s ( 2 . 8 g m , 60%) 
mp 1 7 8 - 1 7 9 ° , R f . 4 6 ( C H C ^ - C R ^ O H , 4 : 1 ) . 
T h e n m r ( D M S 0 - d 6 ) s h o w e d p e a k s a t 6 9 . 9 6 ( 1 H , s , NNH) , 8 . 1 8 ( 1 H , d , 
CHCHNNH), 7 . 9 2 ( 1 H , s , H C O ) , 7 . 1 0 ( 5 H , s , P h ) , 6 . 9 7 ( 1 H , b , C0NHCH) , 6 . 1 9 ( 2 H , 
s , C 0 N H 2 ) , 4 . 6 0 ( 1 H , m, NHCHC0) , 2 . 8 0 ( 2 H , d , CH^Ph) 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 2 3 4 ( M + , 5 . 3 % ) , 
1 8 9 ( ( M - H C 0 N H 2 ) + , 5 . 7 % ) , 1 7 4 PhCH 2 CHCHNNHC0+, 6 . 1 % ) , 1 4 3 ( M - C ? H 7 ) + , b a s e 
p e a k ) , 1 0 0 ( H C O N H C H C H N N H 2 + , 7 7 . 2 % ) , 9 1 ( 0 ^ + , 9 5 . 6 % ) . 
A n a l . C a l c d f o r C 1 1 H 1 4 N 4 ° 2 : C > 5 6 - 4 l ; H , 5 . 9 8 ; N , 2 3 . 9 3 . 
F o u n d : C, 5 6 . 5 1 ; H , 6 . 1 2 ; N , 2 3 . 7 9 . 
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N - A c e t y l - L - A l a n i n e ( A c - A l a - O H ) 
T h e a c e t y l a t i o n o f L - a l a n i n e w a s a c c o m p l i s h e d b y a d d i n g d r o p w i s e 
a c e t i c a n h y d r i d e ( 4 0 . 0 m l , 0 . 4 7 m ) t o L - a l a n i n e ( 5 1 . 1 g m , 0 . 5 7 m ) i n 
r e f l u x i n g g l a c i a l a c e t i c a c i d ( 3 0 0 m l ) . A f t e r s t i r r i n g f o r a n a d d i ­
t i o n a l 2 0 m i n u t e s , t h e r e a c t i o n m i x t u r e w a s c o o l e d t o r o o m t e m p e r a t u r e 
b y t h e a d d i t i o n o f w a t e r ( 1 0 0 m l ) a n d t h e n e v a p o r a t e d t o a y e l l o w o i l . 
T h e o i l w a s w a s h e d w i t h h o t b e n z e n e ( 2 5 0 m l ) , t h e b e n z e n e w a s r e m o v e d , 
a n d t h e r e s u l t i n g o i l t r e a t e d w i t h e t h y l a c e t a t e ( 3 7 5 m l ) . T h e p r o d u c t 
w h i c h c r y s t a l l i z e d i m m e d i a t e l y w a s i s o l a t e d a n d r e c r y s t a l l i z e d f r o m h o t 
e t h y l a c e t a t e t o y i e l d a w h i t e s o l i d ( 5 0 . 5 g m , 6 7 % ) m p 1 2 6 - 1 2 7 ° , 
[ c t ] ^ 3 = - 6 5 . 7 ° ( C 3 . 8 , H 2 0 ) ; B i r n b a u m e t a l . ( 1 9 5 2 ) r e p o r t m p 1 2 5 ° , 
[a]*5 = - 6 6 . 2 ° ( C 2 . 0 , H 2 0 ) . 
N - B e n z y l o x y c a r b o n y l - L - P h e n y l a l a n i n e N - M e t h y l a n i l i d e ( Z - P h e - N ( M e ) P h ) . 
T h e N - m e t h y l a n i l i d e o f N - b e n z y l o x y c a r b o n y l - L - p h e n y l a l a n i n e w a s 
p r e p a r e d f r o m Z - P h e - O H a n d N - m e t h y l a n i l i n e u s i n g a m i x e d a n h y d r i d e 
c o u p l i n g m e t h o d . O n e e q u i v a l e n t o f i s o b u t y l c h l o r o f o r m a t e ( 2 . 6 m l ) 
w a s added to a s o l u t i o n o f 1 e q u i v a l e n t o f Z-Phe-OH ( 6 . 0 g m , 20 m m o l ) 
a n d 1 e q u i v a l e n t o f N - m e t h y l m o r p h o l i n e ( 2 . 2 m l ) d i s s o l v e d i n a n h y d r o u s 
t e t r a h y d r o f u r a n a t - 1 5 ° . T h i s m i x t u r e w a s s t i r r e d f o r a p p r o x i m a t e l y 
1 0 m i n u t e s , 1 e q u i v a l e n t o f N - m e t h y l a n i l i n e ( 2 . 1 m l ) w a s a d d e d , 
a n d the m i x t u r e s t i r r e d f o r 1 h o u r as t h e s o l u t i o n w a s a l l o w e d t o 
w a r m t o r o o m t e m p e r a t u r e . T h e h y d r o c h l o r i d e s a l t s w e r e f i l t e r e d , w a t e r 
w a s a d d e d , a n d t h e n t h e t e t r a h y d r o f u r a n w a s e v a p o r a t e d . T h e w a t e r s o l u ­
t i o n w a s e x t r a c t e d a t l e a s t t h r e e t i m e s w i t h e t h y l a c e t a t e . T h e c o m ­
b i n e d e t h y l a c e t a t e e x t r a c t s w e r e w a s h e d w i t h 0 . 5 M c i t r i c a c i d a n d 1 . 0 
M N a H C O - a n d t h e n d r i e d o v e r a n h y d r o u s m a g n e s i u m s u l f a t e . E v a p o r a t i o n 
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o f t h e e t h y l a c e t a t e r e s u l t e d i n a c o l o r l e s s o i l . T h i s o i l w a s d i s ­
s o l v e d i n c h l o r o f o r m a n d c h r o m a t o g r a p h e d o n M e r c k s i l i c a g e l G 0 . 0 6 3 
0 . 2 mm. The p r o d u c t e l u t e d w i t h 2% m e t h a n o l i n c h l o r o f o r m t o g i v e a 
c o l o r l e s s o i l ( 6 . 8 g m , 8 7 % ) , R f . 6 5 ( C H C 1 3 - C H 3 0 H , 1 9 : 1 ) . 
T h e n m r s p e c t r u m ( C D C l ^ ) s h o w e d p e a k s a t 6 7 . 0 1 ( 1 5 H , m , P h ) , 
6 . 5 6 ( 1 H , b , N H ) , 5 . 0 1 ( 2 H , s , P h C H _ 2 0 ) , 4 . 6 0 ( 1 H , m , N H C H ) , 3 . 1 3 ( 3 H , s , 
NCH_ 3 ) , 2 . 8 8 ( 2 H , b , CH_ 2 Ph) . 
L - P h e n y l a l a n i n e N - M e t h y l a n i l i d e H y d r o b r o m i d e ( H B r • P h e N ( M e ) P h ) . 
Z - P h e - N ( M e ) P h ( 4 . 0 g m , 1 0 . 3 m m o l ) w a s d e b l o c k e d b y d r o p w i s e 
a d d i t i o n o f a s a t u r a t e d s o l u t i o n o f H B r i n a c e t i c a c i d . T h e r e a c t i o n 
m i x t u r e w a s s t i r r e d f o r a p p r o x i m a t e l y 30 m i n u t e s . T h i s p r o c e d u r e w a s 
r e p e a t e d a g a i n u n t i l v i s i b l e r e a c t i o n c e a s e d . A n h y d r o u s e t h e r ( 2 0 0 m 
w a s t h e n s l o w l y a d d e d t o p r e c i p i t a t e a y e l l o w - o r a n g e o i l . A f t e r v i g o 
o u s l y s h a k i n g t h e r e a c t i o n v e s s e l , t h e e t h e r w a s d e c a n t e d f r o m t h e 
r e s i d u a l o i l . T h e o i l w a s t h e n w a s h e d w i t h s e v e r a l p o r t i o n s o f e t h e r 
The p r o d u c t c r y s t a l l i z e d b u t w a s t o o h y g r o s c o p i c t o i s o l a t e . I t w a s 
i m m e d i a t e l y d i s s o l v e d i n d i m e t h y l f o r m a m i d e ( 1 0 m l ) a n d u s e d i n f u r t h e 
c o u p l i n g r e a c t i o n s . 
A c e t y l - L - A l a n y 1 - L - P h e n y l a l a n i n e N - M e t h y l a n i l i d e ( A c - A l a - P h e - N ( M e ) P h ) 
A c e t y l - L - a l a n i n e ( p r e p a r e d b y t h e a c e t y l a t i o n o f L - a l a n i n e w i t h 
1 e q u i v o f a c e t i c a n h y d r i d e i n h o t g l a c i a l a c e t i c a c i d ) w a s a c t i v a t e d 
u s i n g t h e m i x e d - a n h y d r i d e p r o c e d u r e . A c e t y l - L - a l a n i n e ( 1 . 6 2 g m , 1 2 . 2 
m m o l ) w a s d i s s o l v e d i n a n h y d r o u s t e t r a h y d r o f u r a n a n d c o o l e d t o - 1 5 ° . 
N - m e t h y l m o r p h o l i n e ( 1 e q u i v . ) w a s a d d e d f o l l o w e d b y 1 e q u i v . o f 
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i s o b u t y l c h l o r o f o r m a t e ( 1 . 6 m l ) . D e b l o c k e d Z - P h e - N ( M e ) P h ( 4 g m , 1 2 . 2 
m m , i n 1 0 m l D M F ) w a s a d d e d f o l l o w e d b y 1 e q u i v . N - m e t h y l m o r p h o l i n e 
( 1 . 3 5 m l ) . T h e r e a c t i o n m i x t u r e w a s a l l o w e d t o w a r m t o r o o m t e m p e r a t u r e 
a n d s t i r r i n g w a s c o n t i n u e d f o r 1 h o u r . T h e h y d r o c h l o r i d e s a l t s w e r e 
t h e n f i l t e r e d , w a t e r w a s a d d e d , t h e o r g a n i c s o l v e n t e v a p o r a t e d , a n d t h e 
a q u e o u s s o l u t i o n e x t r a c t e d w i t h e t h y l a c e t a t e . A f t e r a q u e o u s c i t r i c 
a c i d a n d b i c a r b o n a t e w a s h e s , t h e s o l v e n t w a s e v a p o r a t e d a n d g a v e a c o l o r ­
l e s s o i l . P u r i f i c a t i o n w a s e f f e c t e d b y c h r o m a t o g r a p h y o n 0 . 0 6 3 - 0 . 2 m m 
s i l i c a g e l G b y M e r c k . T h e p r o d u c t w h i c h e l u t e d w i t h 4 % m e t h a n o l i n 
c h l o r o f o r m w a s r e c r y s t a l l i z e d f r o m e t h y l a c e t a t e - c y c l o h e x a n e g i v i n g w h i t e 
n e e d l e s ( 2 . 1 g m , 4 7 % ) , m p 1 4 3 . 5 - 1 4 4 , R f . 5 2 ( C H C ^ - M e O H , 1 9 : 1 ) . 
T h e n m r s p e c t r u m ( C D C l ^ ) s h o w e d p e a k s a t 6 7 . 7 7 ( 1 H , d , N H ) , 7 . 0 8 
( 1 0 H , m , P h ) , 6 . 9 0 ( 1 H , b , N H ) , 4 . 7 3 ( 2 H , m , N H C H C O ) , 3 . 2 4 ( 3 H , s , N C J 3 ) , 
2 . 8 7 ( 2 H , m , C H ^ P h ) , 1 . 8 6 ( 3 H , s , C H ^ C O ) , 1 . 3 4 ( 3 H , d , C H ( C H 3 ) C 0 ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 3 6 7 ( M + , 2 . 7 % ) , 2 8 1 
( P h N ( M e ) C O C H ( C H 2 P h ) N H C O + , 1 . 6 % ) , 2 7 6 ( ( M - C y H 7 + , 1 . 0 % ) , 2 6 1 ( ( M - N M e P h ) + , 
1 9 . 5 % ) , 2 3 7 ( P h C H C H C 0 N ( M e ) P h + , 1 5 . 9 % ) , 2 3 3 ( M - C 0 N ( M e ) P h , 2 . 7 % ) , 1 4 6 ( P h C H C H 
( N H ) C 0 + , 2 0 . 0 % ) , 1 2 0 ( P h C H 2 C H N H 2 + , b a s e p e a k ) , 1 1 4 ( C H 3 C O N C H C H ( C H 3 ) C O + , 
1 0 . 5 % ) , 1 0 7 ( P h ( M e ) N H + , 6 8 . 4 % ) , 9 1 ( C y H 7 + , 8 . 6 % ) . 
A n a l . C a l c d f o r c 2 i H 2 5 N 3 ° 3 : C ' 6 8 - 6 7 J H » 6 . 8 1 ; N , 1 1 . 4 4 . 
F o u n d : C, 6 8 . 5 7 ; H , 6 . 7 7 ; N , 1 1 . 3 8 . 
N - A c e t y l - L - P h e n y l a l a n i n a l ( A c - a l a - P h e - H ) 
A c e t y 1 - L - a l a n y l - L - p h e n y l a l a n i n a l w a s p r e p a r e d f r o m t h e N - m e t h y l a n i l -
i d e d e r i v a t i v e o f N - a c e t y l a l a n y l p h e n y l a l a n i n e . A c - A l a - P h e - N ( M e ) P h 
( 4 . 0 g m , 1 0 . 8 m m o l ) w a s d i s s o l v e d i n a n h y d r o u s t e t r a h y d r o f u r a n a n d c o o l e d 
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t o - 1 5 ° . 1 . 1 5 M l i t h i u m a l u m i n u m h y d r i d e i n t e t r a h y d r o f u r a n ( 1 9 m l , 
2 1 . 6 m m o l ) w a s s l o w l y a d d e d d r o p w i s e . S t i r r i n g w a s c o n t i n u e d a n a d d i ­
t i o n a l 75 m i n u t e s a t - 1 5 ° . E x c e s s L i A l H ^ w a s d e s t r o y e d b y s l o w l y a d d ­
i n g d r o p w i s e c o l d 1 M N H ^ C l ( 1 5 m l ) . T h e p r e c i p i t a t e s w e r e t h e n 
f i l t e r e d , t h e t e t r a h y d r o f u r a n e v a p o r a t e d a n d t h e r e s i d u e s u s p e n d e d i n 
e t h y l a c e t a t e . A f t e r e x t r a c t i n g t h e o c c l u d e d s o l i d s w i t h b o i l i n g e t h y l 
a c e t a t e , t h e o r g a n i c f r a c t i o n s w e r e c o m b i n e d , d r i e d o v e r a n h y d r o u s m a g ­
n e s i u m a n d e v a p o r a t e d t o a c r u d e p a l e y e l l o w o i l . 
T h i s o i l w a s d i s s o l v e d i n c h l o r o f o r m a n d c h r o m a t o g r a p h e d o n 1 0 0 -
2 0 0 m e s h F l o r i s i l . E l u t i o n w i t h 3% m e t h a n o l i n c h l o r o f o r m g a v e t h e 
d e s i r e d p r o d u c t a s a c o l o r l e s s g l a s s ( 1 . 2 g m , 4 2 % ) , R f . 4 1 ( C H C l 3 - C H 3 O H , 
9 : 1 ) , i r ( C H C 1 3 ) 1 7 3 0 c m ~ 1 ( C = 0 ) . 
The n m r s p e c t r u m ( C D C 1 3 s h o w e d p e a k s a t 6 9 . 3 8 ( . 5 H , s , C H O ) , 
7 . 1 0 ( 5 H , s , P h ) , 6 . 6 3 ( 2 H , b , N H ) , 4 . 4 3 ( 2 H , m , N H C H ) , 3 . 3 3 ( . 5 H , s , 
C H ( 0 H ) 2 ) , 3 . 0 3 ( 2 H , d , Q H ^ P h ) , 2 . 7 0 ( 1 H , b , C H ( 0 H ) 2 , w h i c h d i s a p p e a r e d 
u p o n a d d i n g D 2 0 ) , 1 . 8 7 ( 3 H , s , CH^CO) , 1 . 2 7 ( 3 H , m , C H ( C H 3 ) C 0 ) 
The m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 262 (M+, 2 .3%), 
2 4 5 ( ( M - 0 H ) + , 2 9 . 7%) , 2 3 4 ( ( M - C 0 ) + , 1 0 . 3 % ) , 201C(245 -CH 3 CO)+, 20 . 0 % ) , 
1 2 0 ( P h C H 2 C H N H 2 + , b a s e p e a k ) , 1 1 4 ( C H 3 C 0 N H C H ( C H 3 ) C 0 + , 3 6 . 0 % ) , 9 1 ( C ? H 7 + , 
8 8 . 6 % ) . The m a s s o f t h e m / e 2 4 4 p e a k ( M - H 2 0 ) was e x a c t l y m e a s u r e d a t 
2 4 4 . 1 2 2 4 ( 2 4 4 . 1 2 1 2 c a l c u l a t e d f o r C, . H - , N o 0 „ ) . 
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I n a d d i t i o n t o t h e d e s i r e d a l d e h y d e , t w o a d d i t i o n a l p r o d u c t s f r o m 
t h e F l o r i s i l c h r o m a t o g r a p h y w e r e i s o l a t e d a n d c r y s t a l l i z e d . 
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N - ( a c e t y l a l a n y l ) - N - p h e n y l - N - m e t h y l - 1 — b e n z y l - l , 2 - e t h y l e n e d i a m i n e 
( A c - A l a - N H C H ( C H 2 P h ) C H 2 N ( M e ) P h ) w a s e l u t e d w i t h 2% m e t h a n o l i n c h l o r o f o r m 
a n d w a s r e c r y s t a l l i z e d f r o m e t h y l a c e t a t e - c y c l o h e x a n e t o y i e l d a w h i t e 
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s o l i d ( . 5 g m , 1 3 % ) , mp 1 8 1 - 1 8 1 . 5 ° , R . 6 0 ( C H C l ^ C R ^ O H , 1 9 : 1 ) . 
The n m r s p e c t r u m ( C D C 1 3 ) s h o w e d p e a k s a t 6 7 . 0 0 ( 1 0 H , m , P h ) , 
6 . 3 6 ( 1 H , b , N H ) , 4 . 3 6 ( 2 H , m , NHCHCO), 3 . 4 5 ( 2 H , t , CHCH^NMePh) , 2 . 9 9 ( 3 H , 
s , N C H 3 ) , 2 . 8 8 ( 2 H , d , C H ^ P h ) , 1 . 8 9 ( 3 H , s , C J ^ C O ) , 1 . 1 3 ( 3 H , d , C H ( C H 3 ) C 0 ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 3 5 3 ( M + , 3 . 3 % ) , 
2 6 7 ( P h N ( M e ) C H 2 C H ( C H 2 P h ) N H C O + , . 7 % ) , 2 2 3 ( P h C H 2 C H C H N ( M e ) P h + , 1 4 . 0 % ) , 
2 0 8 ( P h C H 2 C H C H N P h + , . 6 % ) , 1 3 2 ( P h N ( M e ) C C H 2 + , 2 . 7 % ) , 1 2 0 ( P h N ( M e ) C H 2 + , 
b a s e p e a k ) , 9 1 ( 0 ^ + , 5 . 9 % ) . 
A n a l . C a l c d f o r c 2 i H 2 7 N 3 ° 2 : C » 7 1 * 3 9 H » 7 * 6 5 J N » H - 9 0 . 
F o u n d : C , 7 1 . 4 1 ; H , 7 . 7 0 ; N , 1 1 . 8 8 . 
F u r t h e r e l u t i o n w i t h c h l o r o f o r m - m e t h a n o l ( 1 9 : 1 ) g a v e a s e c o n d 
c r y s t a l l i n e p r o d u c t , N - a c e t y l a l a n y l p h e n y l a l a n i n o l ( A c - A l a - N H C H ( C H ^ P h ) 
C H 2 0 H ) . R e c r y s t a l l i z a t i o n f r o m e t h y l a c e t a t e - c y c l o h e x a n e g a v e . 8 g m , 
(28%) o f a w h i t e s o l i d , mp 1 3 6 - 1 3 & ° , R f . 3 5 ( C H C ^ - C H ^ H , 1 9 : 1 ) , 
The n m r s p e c t r u m ( C D C ^ ) s h o w e d p e a k s a t 6 7 . 2 8 ( 5 H , s , P h ) , 
7 . 1 1 ( 1 H , b , N H ) , 6 . 6 2 ( 1 H , b , N H ) , 4 . 4 5 ( 2 H , m, NHCHCO), 3 . 6 4 ( 2 H , d , 
C i ^ O H ) , 3 . 5 6 ( 1 H , b , OH, w h i c h d i s a p p e a r e d u p o n a d d i n g D ^ ) , 2 . 9 2 ( 2 H , d , 
C H 2 P h ) , 1 . 9 8 ( 3 H , s , C H 3 C 0 ) , 1 . 3 7 ( 3 H , d , C H ( C H 3 ) C 0 ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 2 6 5 ( M + 1 , 2 . 2 % ) , 
2 6 4 ( M + , 1 . 5 % ) , 2 4 6 ( M - H 2 0 , . 3 8 % ) , 2 3 4 ( ( 2 6 5 - C H 2 O H ) + , 9 . 8 % ) , 1 7 3 ( ( M - C ^ H , 
1 5 5 ( ( M - H 2 0 - C 7 H 7 ) + , 1 0 . 5 % ) , 1 3 4 ( P h C H 2 C H 2 C H O + , 1 5 . 8 % ) , 1 3 0 ( C H 3 C O N H C H ( C H 3 ) 
C ( 0 H ) = N H 2 + , 6 5 . 4 % ) , 1 2 0 ( P h C H 2 C H N H 2 + , b a s e p e a k ) , 1 1 4 ( C H 3 C O N H C H ( C H 3 ) C O + , 
8 2 . 0 % ) , 9 1 ( C ? H 7 + , 4 0 . 6 % , 8 6 ( C H 3 C O N H C H ( C H 3 ( + , 5 4 . 1 % ) . 
A n a l . C a l c d f o r c l 4 H 2 0 N 2 0 3 : C » 6 3 * 6 4 » H » 7 * 5 8 J N » 1 0 - 6 0 -
F o u n d : C, 6 3 . 6 5 ; H , 7 . 6 3 ; N , 1 0 . 5 2 . 
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N - A c e t y l - L - A l a n y l - L - P h e n y l a l a n i n a l S e m i c a r b a z o n e 
N - a c e t y l a l a n y l p h e n y l a l a n i n a l s e m i c a r b a z o n e w a s p r e p a r e d b y a d d i n g 
a s o l u t i o n o f s e m i c a r b a z i d e h y d r o c h l o r i d e ( . 9 gm) a n d s o d i u m a c e t a t e 
( 1 . 4 gm) i n w a t e r ( 9 m l ) t o N - a c e t y l a l a n y l p h e n y l a l a n i n a l ( . 9 g m ) . T h e 
r e a c t i o n m i x t u r e w a s v i g o r o u s l y s h a k e n , w a r m e d o n a s t e a m b a t h f o r 1 0 
m i n u t e s , d i l u t e d w i t h 95% e t h a n o l ( 9 m l ) , s h a k e n a g a i n a n d f i n a l l y 
a l l o w e d t o s t a n d a t 0 - 5 ° . A f t e r s e v e r a l d a y s , t h e r e a c t i o n m i x t u r e w a s 
e v a p o r a t e d t o a n o i l i n _ v a c u o . d i s s o l v e d i n 10% m e t h a n o l i n c h l o r o f o r m , 
a n d c h r o m a t o g r a p h e d o n M e r c k s i l i c a g e l 0 . 0 6 3 - 0 . 2 mm. T h e s e m i ­
c a r b a z o n e d e r i v a t i v e w a s e l u t e d w i t h c h l o r o f o r m - m e t h a n o l ( 3 : 1 ) a n d w a s 
r e c r y s t a l l i z e d f r o m m e t h a n o l - a c e t o n e t o g i v e a w h i t e s o l i d ( . 6 g m , 5 5 % ) , 
mp 2 0 6 - 2 0 7 ° , R . 4 8 ( C H C ^ - C H ^ H , 4 : 1 ) , R . 4 8 ( C H C 1 3 - C H 3 0 H , 4 : 1 ) . 
T h e n m r s p e c t r u m ( D M S 0 - d 6 ) s h o w e d p e a k s a t 6 9 . 9 5 ( 1 H , s , N N H ) , 8 . 1 7 ( 1 H , 
b , CHCHNNH), 7 . 9 8 ( l H , b , C 0 N H C H ) , 7 . 2 8 ( 5 1 1 , s , p h ) , 7 . 2 0 ( l H , b , C 0 N H C H ) , 6 . 3 2 ( 2 H , 
s , C 0 N H 2 ) , 4 . 5 0 ( 2 H , m , NHCHCO), 2 . 9 0 ( 2 H , d , P h C j y , 1 . 8 7 ( 3 H , s , CRCO), 
1 . 0 7 ( 3 H , d , C H ( C H _ 3 ) C 0 ) . 
The m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 3 1 9 ( M + , . 2 6 % ) , 
2 6 1 ( C H 3 C 0 N H C H ( C H 3 ) C 0 N H C H ( C H 2 P h ) C = N H + , . 8 8 % ) , 2 3 4 ( C H 3 C 0 N H C H ( C H 3 ) C 0 N H C H 2 
( C H 2 P h ) + , 6 . 4 % ) , 2 2 8 ( ( M - C 7 H 7 ) + , 1 0 . 8 % ) , 1 8 5 ( C H 3 C 0 N H C H ( C H 3 ) C 0 N H C = C H - N = N H 2 + , 
6 . 5 % ) , 1 4 8 ( N H 2 C H ( C H 2 P h ) C 0 + , 4 . 2 % ) , 1 3 0 ( C H 3 C O N H C H ( C H 3 ) C ( O H ) = N H + , 1 8 . 3 % ) , 
1 2 0 ( P h C H 2 C H N H 2 + , 3 9 . 4 % ) , 9 1 ( 0 ^ + , b a s e p e a k ) . 
A n a l . C a l c d f o r c 1 5 H 2 i N 5 0 3 : c » 5 6 . 4 3 ; H , 6 . 5 8 ; N , 2 1 . 9 4 . 
F o u n d : C, 5 6 . 3 3 ; H , 6 . 6 7 ; N , 2 1 . 8 7 . 
3 - ( B e n z y l o x y c a r b o n y l a m i n o ) - 4 - P h e n y l - 1 , 2 - B u t a n e d i o l 
3 - B e n z y l o x y c a r b o n y l a m i n o - 4 - p h e n y l - l , 2 - b u t a n e d i o l w a s p r e p a r e d b y 
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t h e s o d i u m b o r o h y d r i d e r e d u c t i o n o f N - b e n z y l o x y c a r b o n y l p h e n y l a l a n i n e 
h y d r o x y m e t h y I k e t o n e . To a s t i r r e d s o l u t i o n o f Z - P h e - C H ^ O H ( 5 0 mg) i n 
i s o p r o p a n o l ( 6 m l ) w a s a d d e d s o l i d N a B H ^ ( 1 . 6 m g ) . 9 0 m i n u t e s l a t e r , 
w a t e r ( 6 m l ) a n d s o d i u m c h l o r i d e ( . 5 gm) w e r e a d d e d . T h e m i x t u r e w a s 
t h e n e x t r a c t e d w i t h c h l o r o f o r m ( 2 t i m e s ) , d r i e d o v e r a n h y d r o u s m a g ­
n e s i u m s u l f a t e , a n d e v a p o r a t e d t o g i v e a w h i t e s o l i d , mp 1 1 0 - 1 1 1 ° . 
The nmr s p e c t r u m ( C D C 1 3 ) s h o w e d p e a k s a t 6 7 . 2 4 ( 1 0 H , d , P h ) , 
5 . 0 3 ( 2 H , s , P h C H _ 2 0 ) , 3 . 8 5 ( 1 H , b , N H C H ( C H 2 P h ) ) , 3 . 5 5 ( 3 H , m , C H ( 0 H ) C H 2 ( O H ) ) , 
2 . 8 4 ( 4 H , b , C H ( C H 2 P h ) ; a n d t w o OH, w h i c h w e r e e x c h a n g e d u p o n a d d i n g D 2 0 ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 3 1 5 ( M + , 1 3 % ) , 
2 8 4 ( P h C H 2 O C O N H C H ( C H 2 P h ) C H ( O H ) + , . 2 7 % ) , 2 5 4 ( P h C H 2 O C O N H C H ( C H 2 P h ) + , 1 . 7 % ) , 
2 2 4 ( ( M - C H ? ) + , 6 . 4 % ) , 2 1 0 ( P h C H 2 N H C H C H 2 P h + , 3 . 0 % ) , 1 6 4 ( P h C H 2 N H C H C H 2 P h + , 
3 . 4 % ) , 1 1 6 ( C H 2 ( O H ) C H ( O H ) C H = N C O + , 7 0 . 9 % ) 1 0 8 ( P h C H 2 0 H + , 4 3 . 6 % ) , 
9 1 ( C 7 H 7 + , b a s e p e a k ) . 
O x i d a t i o n o f D i o l 
N - B e n z y l o x y c a r b o n y l p h e n y l a l a n i n a l ( Z - P h e - H ) w a s p r e p a r e d b y t h e 
p e r i o d i c a c i d o x i d a t i o n o f 3 - b e n z y l o x y c a r b o n y l a m i n o - 4 - p h e n y l - 1 , 2 - b u t a n e -
d i o l . T h e d i o l ( . 1 6 m m ) w a s d i s s o l v e d i n a n h y d r o u s t e t r a h y d r o f u r a n a n d 
t h e n r e a c t e d w i t h H - I O , ( 6 8 m g ) . A f t e r s t i r r i n g 1 h o u r a t r o o m t e m p e r a -
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t u r e , t h e r e a c t i o n m i x t u r e w a s f i l t e r e d t o r e m o v e p r e c i p i t a t e d i o d i c 
a c i d . The t e t r a h y d r o f u r a n w a s e v a p o r a t e d a n d t h e r e s i d u a l o i l e x t r a c t e d 
w i t h e t h y l a c e t a t e . T h e e t h y l a c e t a t e s o l u t i o n w a s w a s h e d w i t h w a t e r , 
1 M b i c a r b o n a t e , w a t e r , s a t u r a t e d KC1 s o l u t i o n , d r i e d o v e r a n h y d r o u s 
m a g n e s i u m s u l f a t e , a n d e v a p o r a t e d t o a c o l o r l e s s o i l . T h e p u r e p r o d u c t 
w a s i d e n t i c a l ( n m r , TLC) w i t h a n a u t h e n t i c s a m p l e o f Z - P h e - H . 
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3 - ( 2 - N a p h t h y l ) a c r o l e i n ( 2 - C 1 0 H 7 C H = C H - C H O ) w a s p r e p a r e d f r o m 2 - n a p h t h a l d e -
h y d e a n d a c e t a l d e h y d e b y a p r o c e d u r e s i m i l a r t o t h a t r e p o r t e d b y 
I s r a e l a s h v i l i je_t a l _ . ( 1 9 5 1 ) . U p o n w o r k u p , t h e c r u d e a l d e h y d e w a s 
o b t a i n e d a s a b l a c k o i l . P u r i f i c a t i o n w a s e f f e c t e d b y c h r o m a t o g r a p h y 
o n 0 . 0 5 - 0 . 2 mm s i l i c a g e l G. T h e p r o d u c t w a s e l u t e d w i t h 10% e t h y l 
a c e t a t e i n p e n t a n e a n d w a s c r y s t a l l i z e d f r o m e t h y l a c e t a t e - c y c l o h e x a n e 
a s y e l l o w n e e d l e s , mp 1 2 5 - 1 2 6 ° ( J u t z ( 1 9 5 8 ) r e p o r t s mp 1 2 5 ° ) ; R f . 1 8 ( e t h y l 
a c e t a t e - c y c l o h e x a n e , 1 : 1 9 ) ; y ( C H C 1 . J , 1 6 7 8 c m _ 1 ( C = 0 ) ; X ( E t O H ) 
TTlcLX "j TIlcLX 
2 7 4 ( e 3 5 0 0 0 ) a n d 3 1 3 ( £ 3 0 0 0 0 ) . 
T h e n m r s p e c t r u m s h o w e d p e a k s a t 6 9 . 7 0 ( 1 H , d , C H O ) , 7 . 2 - 8 1 ( 8 H , 
c o m p l e x , C 1 Q H 7 C H ) a n d 6 . 7 2 ( 1 H , d o f d , J = 8 H z , C H = C H - C H 0 ) . T h e m a s s 
s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 1 8 2 ( M + , b a s e p e a k ) , 1 6 5 ( ( M - 0 H ) + , 7 . 5 % ) , 
1 5 3 ( ( M - C H O + , 8 0 . 5 % ) , 1 4 1 ( ( M - C H C H 0 ) + , 1 8 . 2 % ) , a n d 1 2 8 ( ( M - C = C H C H 0 ) + , 6 6 . 7 % ) . 
3 - ( l - N a p h t h y l ) a c r o l e i n ( l - C 1 0 H 7 C H = C H - C H 0 ) w a s p r e p a r e d f r o m 1 - n a p h t h a l d e -
h y d e and a c e t a l d e h y d e b y a p r o c e d u r e s i m i l a r t o t h a t r e p o r t e d b y 
I s r a e l a s h v i l i e_t a_ l . ( 1 9 5 1 ) . U p o n w o r k u p , t h e c r u d e a l d e h y d e w a s 
o b t a i n e d a s a y e l l o w o i l ( B . P . 1 9 0 ° / 4 0 0 y ) . P u r i f i c a t i o n w a s e f f e c t e d 
b y c h r o m a t o g r a p h y o n 0 . 0 5 - 0 . 2 mm s i l i c a g e l G. T h e p r o d u c t e l u t e d w i t h 
5% e t h y l a c e t a t e i n p e n t a n e a n d w a s c r y s t a l l i z e d f r o m 5% e t h y l a c e t a t e 
i n c y c l o h e x a n e a s c o l o r l e s s n e e d l e s , m p 4 8 . 5 - 4 9 ° ( J u t z ( 1 9 5 8 ) r e p o r t s 
mp 4 7 - 4 8 ° ) ; . 1 4 ( e t h y l a c e t a t e - c y c l o h e x a n e , 1 : 1 9 ) ; Y m a x ( n e a t ) , 1677 cm 
( C = 0 ) ; ;-. ( E t O H ) 2 5 4 ( £ 2 1 5 0 0 ) a n d 3 4 0 ( £ l 2 5 0 0 ) . 
max 
T h e n m r s p e c t r u m s h o w e d p e a k s a t 6 9 . 7 3 ( l H , d , C H O ) , 7 . 2 - 8 . 3 ( 8 H , 
c o m p l e x . C 1 Q H 7 C H ) , 6 . 6 7 ( 1 H , d o f d , J = 8 H z , C H = C H - C H 0 ) . T h e m a s s s p e c t r u m 
s h o w e d m a j o r p e a k s a t m / e 182 (14+ , 7 1 . 4 % ) 1 6 5 ( ( M - O H ) + , 1 0 . 8 % ) , 1 5 3 ( ( M - C H 0 ) + , 
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b a s e p e a k ) , a n d 1 2 8 ( ( M - C = C H C H O ) + , 2 5 . 8 % ) . 
N - A c e t y l - L - P h e n y l a l a n i n e M e t h y l K e t o n e ( A c - P h e - C H 3 ) 
T h e d i a z o k e t o n e A c - P h e - C H N 2 w a s p r e p a r e d f r o m a c e t y l - L - p h e n y l a l a -
n i n e a n d d i a z o m e t h a n e u s i n g a m i x e d - a n h y d r i d e p r o c e d u r e . A c - P h e - O H 
( 1 . 0 g m , 5 m m o l ) w a s d i s s o l v e d i n t e t r a h y d r o f u r a n a n d c o o l e d t o - 1 0 ° i n 
a t h r e e - n e c k e d f l a s k e q u i p p e d w i t h s t i r r e r , d r y i n g t u b e a n d t h e r m o m e t e r . 
N - m e t h y l m o r p h o l i n e ( . 5 5 m l , 5 m m o l ) w a s a d d e d , f o l l o w e d b y i s o b u t y l c h l o r o -
f o r m a t e ( . 6 5 m l , 5 m m o l ) ; m i x e d a n h y d r i d e f o r m a t i o n w a s p r a c t i c a l l y 
i n s t a n t a n e o u s . A f t e r c a 10 m i n u t e s , t h e N - m e t h y l m o r p h o l i n e s a l t s w e r e 
f i l t e r e d a n d d i a z o m e t h a n e ( 1 0 m m o l ) a d d e d . T h e r e a c t i o n m i x t u r e w a s 
a l l o w e d t o s t a n d o v e r n i g h t a t 4 ° C . E x c e s s 5 1 % h y d r i o d i c a c i d w a s a d d e d 
a t 5 ° C . S t i r r i n g w a s c o n t i n u e d u n t i l n i t r o g e n e v o l u t i o n d i m i n i s h e d . 
A f t e r w o r k u p o f t h e r e a c t i o n m i x t u r e , t h e r e s u l t i n g c r u d e o i l w a s c h r o m a t o -
g r a p h e d o n s i l i c a g e l . T h e p r o d u c t w a s e l u t e d w i t h 3% m e t h a n o l i n c h l o r o ­
f o r m a n d r e c r y s t a l l i z e d f r o m e t h y l a c e t a t e - c y c l o h e x a n e t o g i v e w h i t e 
n e e d l e s , mp 1 2 0 - 1 2 0 . 5 , . 4 7 ( c h l o r o f o r m - m e t h a n o l , 9 : 1 ) . T h e n m r s p e c ­
t r u m ( C D C 1 3 ) s h o w e d p e a k s a t 6 7 . 2 3 ( 5 H , s , P h ) , 7 . 1 2 ( 1 H , b , N H ) , 
4 . 8 5 ( 1 H , m , NHCHC0) , 3 . 0 9 ( 2 H , d , PhCH C H ) , 2 . 1 3 ( 3 H , s , C H C O C i y , 
1 . 9 4 ( 3 H , s , CH C 0 N H ) . 
T h e m a s s s p e c t r u m s h o w e d m a j o r p e a k s a t m / e 2 0 5 ( M + , 3 % ) , 1 6 2 ( A c -
N H C H ( C H 2 P h ) + , 5 0 % ) , 1 2 0 ( N H 2 C H ( C H 2 P h ) + , b a s e p e a k ) , 9 1 ( 0 ^ + , 2 8 % ) , 
4 3 ( C H 3 C 0 + , 3 8 % ) . 
A n a l . C a l c d f o r C 1 2 H 1 5 N ° 2 : ° 9 7 0 , 2 4 ; H » 7 , 3 2 ; N > 6 ' 8 3 * 
F o u n d : C, 7 0 . 3 4 ; H , 7 . 4 0 ; N , 6 . 7 7 . 
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R e a c t i o n o f C h y m o t r y p s i n w i t h I n h i b i t o r s 
The c o m p e t i t i v e i n h i b i t i o n o f c h y m o t r y p s i n w a s c a r r i e d o u t 
u n d e r p s e u d o - f i r s t - o r d e r c o n d i t i o n s a t 2 5 . 0 ° ± . 5 a n d pH 7 . 8 0 ± . 1 0 . 
S t o c k i n h i b i t o r s o l u t i o n s w e r e p r e p a r e d b y d i s s o l v i n g a w e i g h e d a m o u n t 
o f i n h i b i t o r i n 1 , 2 - d i m e t b o x y e t h a n e (DME) w h i c h h a d b e e n r e d i s t i l l e d 
o v e r CaH2 a n d s t o r e d o v e r m o l e c u l a r s i e v e s . I n h i b i t o r s o l u t i o n s a t 
a p p r o p r i a t e c o n c e n t r a t i o n s w e r e p r e p a r e d b y s e r i a l d i l u t i o n o f t h e s t o c k 
s o l u t i o n s w i t h DME. A s t o c k s o l u t i o n o f c h y m o t r y p s i n , p r e p a r e d i n 
1 . 0 mM H C 1 , w a s s t o r e d a t 4 ° a n d h a d a c o n c e n t r a t i o n o f 13mM o r 3 . 1 m g / m l 
a s d e t e r m i n e d b y u v a b s o r b a n c e a t 282 n m . N - a c e t y l - L - t y r o s i n e e t h y l e s t e r 
( A c - T y r - O E t ) s o l u t i o n s w e r e p r e p a r e d b y s e r i a l d i l u t i o n o f a 5 mM 
A c - T y r - O E t s o l u t i o n c o n t a i n i n g 0 . 1 J _ C a C l 2 a n d 5% ( v / v ) D M E . T h e i n h i b i ­
t i o n r e a c t i o n w a s b e g u n b y a d d i n g 1 0 0 \ii o f a n i n h i b i t o r s o l u t i o n t o 
1 0 . 0 m l o f a n A c - T y r - O E t s o l u t i o n , a d j u s t i n g t h e pH t o 7 . 8 , a n d t h e n 
a d d i n g a 1 0 0 u £ a l i q u o t o f a n e n z y m e s o l u t i o n w h i c h h a d b e e n p r e p a r e d b y 
d i l u t i n g 0 . 2 m l o f t h e s t o c k c h y m o t r y p s i n s o l u t i o n w i t h d i s t i l l e d w a t e r . 
T h e f i n a l e n z y m e c o n c e n t r a t i o n w a s 0 . 0 2 3 u M. T h e r a t e o f h y d r o l y s i s o f 
A c - T y r - O E t b y c h y m o t r y p s i n w a s m e a s u r e d p o t e n t i o m e t r i c a l l y u s i n g a p H -
s t a t . A l l a s s a y s w e r e c a r r i e d o u t i n a t h e r m o s t a t e d v e s s e l u n d e r a 
n i t r o g e n a t m o s p h e r e . T h e t i t r a n t u s e d w a s 0 . 0 4 7 0 F_ NaOH ( 0 . 1 0 8 5 J_ i n 
some l a t e r r u n s ) . T h r e e s u b s t r a t e c o n c e n t r a t i o n s ( 1 . 0 , 2 . 0 a n d 3 . 0 mM 
A c - T y r - O E t ) w e r e u s e d f o r e a c h i n h i b i t o r c o n c e n t r a t i o n w i t h e a c h p o i n t 
b e i n g r e p l i c a t e d a t l e a s t t w o t i m e s . I n i t i a l v e l o c i t i e s w e r e o b t a i n e d 
f r o m t h e p H - s t a t r e c o r d e r t r a c i n g s b y t h e m e t h o d o f H e n d e r s o n ( 1 9 7 1 ) . 
F o r e a c h i n h i b i t o r a v a l u e o f t h e d i s s o c i a t i o n c o n s t a n t , K , w a s 
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calculated from an Eadie-Hofstee form of the Michaelis-Menton equation 
(eq. 2) 
V 
v max v ( 2 ) 
S (1 + Y~ ) (K ) (1 + ±-) (K ) Kj m m 
using a least-squares computer program. Correlation coefficients of 
better than 0.96 were obtained throughout. 
Reaction of Subtilisin with Inhibitors 
The competitive inhibition of subtilisin BPN' was carried out 
under conditions virtually identical with those employed in the inhibi­
tion reactions with chymotrypsin. Solutions of inhibitor and substrates 
were made up to the correct concentrations as previously described for 
chymotrypsin. A stock subtilisin solution was freshly prepared each 
day by dissolving 1.9 mg of enzyme in 1.0 ml of a 0.1 M phosphate buffer 
at pH 7.0. The enzyme concentration was determined by uv absorbance at 
280 nm. The inhibition reaction was initiated by adding 100 y51 of an 
inhibitor solution to 10.0 ml of an Ac-Tyr-OEt solution, adjusting the 
pH to 7.8, and then adding a 250 yJl aliquot of an enzyme solution which 
had been prepared by diluting 0.5 ml of the stock subtilisin solution 
with distilled water. The inhibition kinetics were assayed and analyzed 
as previously described for chymotrypsin. 
Preparation of Crystals of Chymotrypsin A^ for X-ray Analysis. 
Crystallization leading to a limited number of single crystals of 
uniform size was carried out as follows. Lyophilized chymotrypsin A^ 
(120 mg) was dissolved in 1 mM HC1 to a concentration of 60 mg/ml. The 
2 8 
c o n c e n t r a t e d e n z y m e s o l u t i o n ( 2 m l ) w a s f i l t e r e d t h r o u g h a 0 . 9 x 25 cm 
c o l u m n o f G - 2 5 f i n e S e p h a d e x w h i c h h a d b e e n t h o r o u g h l y p r e w a s h e d w i t h 
d i s t i l l e d w a t e r . A n e f f l u e n t f r a c t i o n o f 4 . 0 m l c o n t a i n i n g m o s t o f t h e 
p r o t e i n ( a s i n d i c a t e d b y t r i c h l o r o a c e t i c a c i d p r e c i p i t a t i o n ) w a s c o l ­
l e c t e d i n a d u s t f r e e c o n t a i n e r , a n d t h e pH a d j u s t e d t o 5 . 6 . A l i q u o t s 
( 2 m l ) o f t h e s o l u t i o n w e r e m i x e d i n s m a l l d u s t f r e e c r y s t a l d i s h e s 
w i t h e q u a l v o l u m e s o f a s a l t s o l u t i o n , 4 . 0 M ( N H ^ ) 2 S O ^ - 0 . 0 2 M c a c o d y l a t e 
b u f f e r ( p H 5 . 6 ) . C a r e w a s t a k e n n o t t o n u c l e a t e t h e s o l u t i o n d u r i n g m i x ­
i n g . The f i n a l e n z y m e c o n c e n t r a t i o n w a s c a . 15 m g / m l . 
T h e d i s h e s w e r e s e e d e d b y t o u c h i n g t h e l i q u i d s u r f a c e w i t h a g l a s s 
f i b e r t h a t h a d b e e n d i p p e d i n t o t h e m o t h e r l i q u o r o f a s t o c k p r e p a r a t i o n 
o f t e t r a g o n a l A ^ c r y s t a l s . E a c h d i s h w a s t h e n s e a l e d a n d s t o r e d a t 2 0 ° . 
W e l l - f o r m e d t e t r a g o n a l b i p y r a m i d s ( t h e c h a r a c t e r i s t i c c r y s t a l l i n e h a b i t 
o f b o v i n e y - c h y m o t r y p s i n ) , a p p e a r e d w i t h i n a w e e k . When t h e s e c r y s t a l s 
h a d r e a c h e d t h e s i z e o f 0 . 3 - 0 . 5 mm i n t h e l o n g e s t d i m e n s i o n ( a b o u t t w o 
m o n t h s ) , t h e y w e r e u s e d i n t h e x - r a y s t u d i e s . 
P r e p a r a t i o n o f T e t r a g o n a l A^ C r y s t a l s f r o m C h y m o t r y p s i n o g e n 
S e e d c r y s t a l s o f c h y m o t r y p s i n A^ w e r e g r o w n f r o m e n z y m e f r e s h l y 
d e r i v e d f r o m z y m o g e n b y r a p i d a c t i v a t i o n ( W i l c o x , 1 9 7 0 ) . C h y m o t r y p s i n o g e n 
( l . l g ) w a s t r e a t e d w i t h a c e t y l - t r y p s i n ( 4 0 mg) a t 5 ° a n d pH 7 . 5 f o r 1 
h r . T h e m i x t u r e o f e n z y m e s p e c i e s w a s t h e n s e p a r a t e d o n C M - c e l l u l o s e a t 
5 ° u s i n g a . 0 7 5 - . 2 2 5 M p h o s p h a t e l i n e a r g r a d i e n t ( p H 6 . 2 ) . T h e m a j o r 
f r a c t i o n c o n s i s t i n g o f A^ w a s c o l l e c t e d , t h e pH a d j u s t e d t o 4 . 0 , a n d t h e 
p r o t e i n c o n c e n t r a t e d i n a n A m i c o n D i a f l o a p p a r a t u s , u s i n g UM 20 m e m b r a n e s . 
D u r i n g t h i s s t a g e o f t h e p r e p a r a t i o n , t h e A s p e c i e s w a s l a r g e l y c o n v e r t e d 
29 
t o A ^ . T h e c o n c e n t r a t e d e n z y m e s o l u t i o n w a s t h e n f i l t e r e d t h r o u g h G - 2 5 
f i n e S e p h a d e x . A f t e r a d j u s t i n g t h e pH t o 5 . 6 , a l i q u o t s o f t h e s o l u t i o n 
w e r e m i x e d w i t h e q u a l v o l u m e s o f t h e s a t u r a t e d a m m o n i u m s u l f a t e - c a c o d y l a t e 
b u f f e r s a l t s o l u t i o n p r e v i o u s l y d e s c r i b e d . E a c h d i s h w a s t h e n s e a l e d 
a n d s t o r e d a t 2 0 ° . S m a l l s e e d c r y s t a l s a p p e a r e d s e v e r a l m o n t h s l a t e r . 
P r e p a r a t i o n o f I n h i b i t e d C r y s t a l s f o r X - R a y A n a l y s i s 
C h y m o t r y p s i n A ^ c r y s t a l s , g r o w n f r o m a h a l f - s a t u r a t e d a m m o n i u m 
s u l f a t e (pH 5 . 6 ) s a l t s o l u t i o n , w e r e a l l o w e d t o s o a k i n 2 . 4 M p h o s p h a t e 
( p H 5 . 6 ) f o r 1 d a y t o r e m o v e ( N H ^ ^ S O ^ . R e a c t i o n o f t h e c r y s t a l s w i t h 
e a c h o f t h e t w o i n h i b i t o r s , A c - A l a - P h e - H a n d Z - P h e - H , w a s c a r r i e d o u t b y 
t h e f o l l o w i n g p r o c e d u r e . Some o f t h e a l d e h y d e w a s d i s s o l v e d i n a c e t o n i -
t r i l e . T h i s s o l u t i o n w a s t h e n m i x e d w i t h t h e 2 . 4 M p h o s p h a t e ( p H 5 . 6 ) 
s a l t s o l u t i o n t o g i v e a 1 -2% a c e t o n i t r i l e m i x t u r e ; Y - c r y s t a l s w e r e s e e n 
t o b e s o l u b l e i n s a l t s o l u t i o n s c o n t a i n i n g 3 -4% a c e t o n i t r i l e . Some o f 
t h e i n h i b i t o r p r e c i p i t a t e d f r o m t h e m i x t u r e , i n d i c a t i n g s a t u r a t i o n . A 
s l u r r y w a s m a i n t a i n e d b y f r e q u e n t s t i r r i n g a n d w a s e x c h a n g e d s l o w l y w i t h 
t h e s o l u t i o n w h i c h b a t h e d t h e e n z y m e c r y s t a l s . T h e r e a c t i o n w a s a l l o w e d 
t o p r o c e e d a t 2 0 ° w i t h o c c a s i o n a l m i x i n g a n d a d d i t i o n s o f f r e s h i n h i b i t o r 
s o l u t i o n . A f t e r a p p r o x i m a t e l y 2 w e e k s s o a k i n g , t h e c r y s t a l s w e r e t h e n 
u s e d f o r x - r a y a n a l y s i s s i n c e t h e i n h i b i t e d c r y s t a l s b e g a n t o s i g n i f i ­
c a n t l y c r a c k a f t e r 3 - 4 w e e k s s o a k i n g . 
X - r a y D a t a C o l l e c t i o n 
I n h i b i t e d y-chymotrypsin c r y s t a l s o f s u i t a b l e s i z e , t y p i c a l l y 
0 . 5 mm x 0.3 mm, w e r e c a r e f u l l y p o s i t i o n e d i n a c i d - w a s h e d c a p i l l a r y t u b e s 
made o f L i n d m a n n g l a s s . T h e c - a x i s ( l o n g e s t d i m e n s i o n ) w a s o r i e n t e d 
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approximately parallel to the capillary axis. Excess liquid was removed 
using slivers of filter paper, but the base of a crystal was left in a 
slight puddle. After sealing, the capillary tube was glued to a stand­
ard size metal pin, and the pin was then mounted on a standard goniometer 
head. 
Crystals were aligned and centered on a Buerger precession camera 
fitted with a Polaroid XR-7 film cassett. Intensity data was collected 
by the precession method using Illford Industrial G X-ray film. Precession 
photographs at 8 and 16 hrs were obtained for the hOl level of each 
o 
derivative crystal using filtered CuK^ radiation (A = 1.53 A). The 
crystal-to-film distance was 100 mm, and the precession angle was 16°45'. 
A screen of 10 mm radius and a spacing of 33.3 mm were also used. All zero-
level photographs, taken at spindle settings found during alignment and 
centering, possessed mirror-mirror symmetry. Integrated intensities were 
measured from these precession films using an automated microdensitometer. 
Control photographs of uninhibited crystals were supplied by Mr. D. 
Carroll. 
Ultraviolet Absorption Studies 
Ultraviolet absorption spectra were measured with matched, two-com­
partment cuvets (path length, 0.44 cm per compartment) and a Beckman 
Model 25 recording spectrophotometer. Aldehyde solutions were freshly 
prepared by dissolving weighed amounts of 3 - (2-naphthyl)acrolein and 
6-(1-naphthyl) acrolein in 1,2-dimethoxyethane (DME) and diluting with 
pH 7.8 buffer (.1 M phosphate) resulting in a 10% DME solution. A 
stock solution of chymotrypsin A was prepared in 1 mM HC1 and had a 
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c o n c e n t r a t i o n o f 0 . 1 1 mM b y u v a b s o r b a n c e . S p e c t r a w e r e r e c o r d e d a t 
a m b i e n t t e m p e r a t u r e f r o m 4 1 0 nm t o 2 3 0 nm w i t h a l d e h y d e ( c o m p a r t m e n t 1 ) 
a n d e n z y m e ( c o m p a r t m e n t 2 ) i n t h e s a m p l e b e a m v s . 1 M p h o s p h a t e b u f f e r , 
pH 7 . 8 , i n t h e r e f e r e n c e b e a m . W i t h i n 5 m i n u t e s o f m i x i n g t h e a l d e h y d e 
a n d e n z y m e s o l u t i o n s c o n t a i n e d i n t h e s a m p l e c u v e t t e , s p e c t r a w e r e a g a i n 
r e c o r d e d o v e r t h e same w a v e l e n g t h r a n g e . B e f o r e m i x i n g , c o n c e n t r a t i o n s 
w e r e a s f o l l o w s : 2 - C 1 0 H 7 C H = C H - C H O , 30 o r 60 y M ; 1 - C 1 C ) H 7 C H = C H - C H 0 , 1 2 5 
o r 2 5 0 y M ; y ~ c n y m o t r y p s i n , 3 o r 1 1 0 y M . 
I n s e p a r a t e e x p e r i m e n t s , d i f f e r e n c e s p e c t r a w e r e m e a s u r e d w i t h 
a l d e h y d e ( c o m p a r t m e n t 1 ) a n d c h y m o t r y p s i n ( c o m p a r t m e n t 2 ) i n t h e s a m p l e 
b e a m v s a l d e h y d e a n d c h y m o t r y p s i n ( c o m p a r t m e n t 1 ) a n d pH 7 . 8 p h o s p h a t e 
b u f f e r ( c o m p a r t m e n t 2 ) i n t h e r e f e r e n c e b e a m . I n o r d e r t o m i n i m i z e 
e r r o r , t h e same p i p e t w a s u s e d t o p r e p a r e t h e s a m p l e a n d r e f e r e n c e m i x ­
t u r e s . C h y m o t r y p s i n w a s a d d e d t o t h e c u v e t s w i t h i n 15 m i n u t e s o f 
r e c o r d i n g t h e s p e c t r u m f r o m a s t o c k s o l u t i o n ( 0 . 1 1 m M ) . F i n a l c o n c e n ­
t r a t i o n s w e r e : 2 - C 1 C ) H 7 C H = C H - C H O , 15 o r 30 y M ; 1 - C 1 ( ) H 7 C H = C H - C H 0 , 75 o r 
125 y M ; Y - c h y m o t r y p s i n , 55 y M . C o n t r o l r u n s , i n w h i c h b u f f e r w a s s u b ­
s t i t u t e d f o r t h e e n z y m e o r t h e i n h i b i t o r , w e r e a l s o p e r f o r m e d . A l l 
s p e c t r a w e r e r e c o r d e d f r o m 4 5 0 nm t o 2 4 0 nm a t 0 . 1 a b s o r b a n c e u n i t s 
f u l l s c a l e . 
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CHAPTER III 
normal substrate peptide fluoromethyl ketone 
For example, the fluorine atom was not expected to participate in 
RESULTS AND DISCUSSION 
Efforts were directed toward the development and study of a 
structural model of the tetrahedral enzyme-substrate complex preceding 
acyl enzyme formation. Specific goals were: a) the synthesis of a 
small inhibitor molecule resembling a natural substrate that would 
complex with either chymotrypsin or subtilisin such that the enzyme 
active site serine had added to the carbonyl group of the inhibitor. 
This derivative would be analogous to the tetrahedral intermediate 
observed in the enzymatic hydrolysis of the peptide bond by serine 
proteases; b) a kinetic and crystallographic investigation of this 
derivative. 
Synthesis of the Inhibitors 
Peptide fluoromethyl ketones were initially chosen to serve as 
our substrate analogs. Because peptide fluoromethyl ketones are struc­
turally similar to normal chymotrypsin substrates, they were considered 
to be ideal analogs. 
RCONHCHCONHR" RC0NHCHC0CHoF 
I I 2 
R' Rf 
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nucleophilic displacement reactions. Hence, fluoromethyl ketones would 
probably not react with the enzyme's active site histidine residue. 
The fluoromethyl ketone functional group (COCĤ F), moreover, is about 
the same size and shape as a normal peptide amide bond and, due to the 
electronegative fluorine atom, might be expected to have almost the 
same polarity as a peptide bond. Thus, a complex of a peptide fluoro­
methyl ketone with chymotrypsin might exist in a form in which the active 
site serine (Ser-195) had added across the carbonyl group. This non­
productive adduct would be expected to be an analog of the tetrahedral 
intermediate found to intervene in chymotrypsin acylation and deacylation 
and as such, would be a good candidate for x-ray crystallography. 
Although many different synthetic schemes and chemical systems were tried, 
attempts to prepare these peptide fluoromethyl ketones were not success­
ful. For example, the reaction of a peptide diazoketone with anhydrous 
HF did not yield the expected fluoroketone even though analogous methods 
had been used to prepare chloromethyl ketones (Shaw, 1967). Instead a 
cyclization reaction occurred (eq. 3). The products 
0 
0 ii 
I HF Q^^NH 
H Ĉ Ĥ CĤ OCNHCHCOCHN,, > _ 
6 5 2 , 2 H2 
(3) 
CHC H fl C H 2 C 6 H 5 2 6 5 Q 
of the reactions of peptide iodomethyl ketones with AgF, on the other 
hand, were found to be the corresponding alcohols (eq. 4) 
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A g F 
RCONHCHCOCH 2± > RCONHCHCOCH2OH (4) 
| a q u e o u s | 
C H 2 C 6 H 5 C H 2 C 6 H 5 
a n d n o t t h e e x p e c t e d p r i m a r y a l k y l h a l i d e s ( T a n n h a u s e r e_t a l . , 1 9 5 6 ) . 
F a i l i n g t o r e a l i z e o u r g o a l s w i t h p e p t i d e f l u o r o m e t h y l k e t o n e s , 
e f f o r t s w e r e t h e n d i r e c t e d t o w a r d d e v e l o p i n g a l d e h y d e a n a l o g s o f p e p ­
t i d e s u b s t r a t e s . B e i n g a b o u t t h e same s i z e a n d s h a p e a s a p e p t i d e b o n d , 
t h e a l d e h y d e f u n c t i o n a l g r o u p w a s c o n s i d e r e d t o b e i d e a l . M o r e o v e r , 
a l d e h y d e s a r e k n o w n t o b e v e r y s u s c e p t i b l e t o c a r b o n y l a d d i t i o n r e a c t i o n s 
a n d a r e f r e q u e n t l y u n s t a b l e i n a q u e o u s o r a l c o h o l s o l u t i o n , f o r m i n g 
h y d r a t e s o r h e m i a c e t a l s . H e n c e , t h e h e m i c e t a l ( I ) , w h i c h i s p r o b a b l y 
f o r m e d w h e n a s e r i n e p r o t e a s e i n t e r a c t s w i t h a n a l d e h y d e a n a l o g , s h o u l d 
r e s e m b l e t h e h i g h l y a c t i v a t e d t e t r a h e d r a l i n t e r m e d i a t e s u g g e s t e d i n n o r ­
m a l s u b s t r a t e h y d r o l y s i s o f p e p t i d e b o n d s . R e c e n t s t u d i e s 
E n z y m e E n z y m e 
I I 
OH 0 




h a v e s h o w n t h a t a l d e h y d e a n a l o g s o f s p e c i f i c s u b s t r a t e s a r e p o t e n t 
c o m p e t i t i v e i n h i b i t o r s o f t r y p s i n , c h y m o t r y p s i n e l a s t a s e a n d p a p a i n , 
b i n d i n g m a n y t i m e s m o r e t i g h t l y t h a n s u b s t r a t e s . F o r e x a m p l e , t w o 
p e p t i d e a l d e h y d e s a n a l o g o u s t o a m i d e s u b s t r a t e s o f e l a s t a s e h a v e b e e n 
s y n t h e s i z e d b y T h o m p s o n ( 1 9 7 3 ) a n d s h o w n t o b i n d t o t h e e n z y m e u p t o 
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5 0 0 0 - f o l d m o r e t i g h t l y t h a n t h e s u b s t r a t e s . A l d e h y d e s , s t r u c t u r a l l y 
r e l a t e d t o t h e a c y l p o r t i o n o f p a p a i n s u b s t r a t e s , h a v e a l s o b e e n s y n ­
t h e s i z e d a n d f o u n d t o b e e x t r e m e l y p o t e n t c o m p e t i t i v e i n h i b i t o r s 
( W e s t e r i k a n d W o l f e n d e n , 1 9 7 2 ) . I n t e r e s t i n g l y , a n o v e l c l a s s o f 
n a t u r a l l y o c c u r r i n g p e p t i d e a l d e h y d e s , l e u p e p t i n s , h a v e b e e n s h o w n t o 
e f f e c t i v e l y i n h i b i t v a r i o u s p r o t e a s e s s u c h a s t r y p s i n a n d p a p a i n 
( A o y a g i e t a l , 1 9 6 9 a , b ; M a e d a , 1 9 7 1 ) , a n d t h e i r s t r u c t u r e s h a v e b e e n 
c o n f i r m e d b y s y n t h e s i s ( S h i m u z u e t a l . , 1 9 7 2 ; K a w a m u r a et_ a l . , 1 9 6 9 , 
K o n d o e t a l . , 1 9 6 9 ) . F u r t h e r m o r e , v a r i o u s s y n t h e t i c a n a l o g s o f t h e s e 
l e u p e p t i n s h a v e d e m o n s t r a t e d m a r k e d i n h i b i t i o n o f c h y m o t r y p s i n ( I t o , 
e t a l . , 1 9 7 2 ) . 
T h e s y n t h e s i s o f p e p t i d e s c o n t a i n i n g a l d e h y d e f u n c t i o n a l g r o u p s 
r e p r e s e n t s a r a t h e r n e w e x p e r i m e n t a l e n d e a v o r i n s y n t h e t i c p e p t i d e 
c h e m i s t r y . G u i d e d b y t h e s t u d i e s o f s e v e r a l J a p a n e s e w o r k e r s ( I t o , et_ a l , 
1 9 7 2 ; S a e k i e t a l . , 1 9 7 3 , S h i m u z u e t a l . , 1 9 7 2 ) , t h e s y n t h e s i s o f t h r e e 
P ^ - p h e n y l a l a n i n e p e p t i d e a l d e h y d e s w a s u n d e r t a k e n . T h e d i p e p t i d e 
a l d e h y d e , A c - A l a - P h e - H ( I I ) , w a s t o b e p r e p a r e d f r o m Z - P h e - H ( I I I ) f o r u s e 
0 
II 
R-NHCHC-H R = A c - A l a - ( I I ) 
Z - ( I I I ) 
CHO- ( I V ) 
c r y s t a l l o g r a p h y s t u d i e s w i t h c h y m o t r y p s i n A y . C H O - P h e - H ( I V ) , o n t h e o t h e r 
h a n d , w a s d e s i g n e d f o r u s e w i t h a - c h y m o t r y p s i n s i n c e t h i s e n z y m e c r y s t a l 
l a t t i c e w a s n o t e x p e c t e d t o a c c o m m o d a t e l a r g e r p e p t i d e s ( B i r k t o f t e £ a l . , 
1 9 7 0 ) . Two o f t h e s e i n h i b i t o r s , C H O - P h e - H a n d Z - P h e - H w e r e s u c c e s s f u l l y 
s y n t h e s i z e d b y r e d u c i n g t h e i m i d a z o l i d e s o f CHO-Phe-OH a n d Z - P h e - O H w i t h 
L i A l H ^ i n a n h y d r o u s t e t r a h y d r o f u r a n ( e q . 5 ) . R e d u c t i o n o f c a r b o x y l i c a c i d 
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0 \ r I 0 / — N l ) L i A T H . 0 
II N ' 2 || / \ ' 4 II 
R - N H - C H - C - O H > R - N H - C H - C - > R - N H - C H - C - H 
C H n C . H c I 2 ) N H . C 1 C H ^ C . H , . 2 6 5 C H 0 C . H C 4 2 6 5 z 6 5 
(5 ) 
i m i d a z o l i d e s w i t h L i A l H ^ was o r i g i n a l l y r e p o r t e d by S t a a b and B r a u n l i n g 
( 1 9 6 2 ) bu t f i r s t a p p l i e d to p e p t i d e i m i d a z o l e d e r i v a t i v e s by S h i m i z u and 
c o w o r k e r s i n 1 9 7 2 . L i t t l e r a c e m i z a t i o n was r e p o r t e d to have o c c u r r e d 
d u r i n g t h e s e r e d u c t i o n s . 
C r y s t a l l i n e Z - P h e - H was o b t a i n e d r e a d i l y a f t e r c h r o m a t o g r a p h i c 
p u r i f i c a t i o n . C o n v e r s i o n o f the a l d e h y d e to the c o r r e s p o n d i n g s e m i c a r ­
bazone c o n f i r m e d o u r s y n t h e s i s . A n a l t e r n a t i v e s y n t h e s i s o f Z - P h e - H was 
e f f e c t e d by s o d i u m b o r o h y d r i d e r e d u c t i o n o f the h y d r o x y m e t h y l k e t o n e , 
Z - P h e - C H ^ O H , f o l l o w e d by p e r i o d i c a c i d o x i d a t i o n o f the r e s u l t i n g 1 , 2 - d i o l 
( e q . 6 , R = Z - N H - C H ( C H 2 e 6 H ) - ) . 
0 OH OH 0 
|| NaBH | | H 10 || 
R - C - C H 2 0 H ^ > R - C H - C H 2 — - — — > R - C - H (6 ) 
P u r i f i c a t i o n o f f o r m y l p h e n y l a l a n i n a l ( C H O - P h e - H ) p r e s e n t e d 
f o r m i d a b l e d i f f i c u l t i e s . T h i s compound was e v e n t u a l l y o b t a i n e d a s a 
c o l o r l e s s o i l by h i g h p r e s s u r e l i q u i d c h r o m a t o g r a p h y . D i s t i l l a t i o n o f 
t h i s o i l p r o v i d e d a n a i r - s e n s i t i v e , bu t c r y s t a l l i n e , w h i t e s o l i d . The 
a l d e h y d e t h u s o b t a i n e d was c h a r a c t e r i z e d a s a c r y s t a l l i n e s e m i c a r b a z o n e . 
S e v e r a l a p p r o a c h e s were c o n s i d e r e d i n o u r a t t e m p t s to p r e p a r e the 
N - a c y l a t e d d i p e p t i d e a l d e h y d e , A c - A l a - P h e - H . B e c a u s e the a l d e h y d e f u n c ­
t i o n a l g r o u p h a s a t endency to r e a c t w i t h amino g r o u p s , the d e s i r e d 
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c o m p o u n d m u s t e i t h e r b e s y n t h e s i z e d a f t e r t h e r e s t o f t h e p e p t i d e h a s 
b e e n c o n s t r u c t e d o r s h o u l d b e p r o t e c t e d ( e . g . b y m e a n s o f a s e m i c a r b a z o n e ) 
d u r i n g c o u p l i n g r e a c t i o n s . T h e f o r m e r a p p r o a c h w a s a d o p t e d a f t e r f a i l i n g 
t o r e m o v e t h e s e m i c a r b a z o n e b l o c k i n g g r o u p . D i r e c t r e d u c t i o n o f t h e 
c o r r e s p o n d i n g i m i d a z o l e d e r i v a t i v e o f A c - A l a - P h e - O H w a s u n s a t i s f a c t o r y 
b e c a u s e o f t h e p o o r s o l u b i l i t y o f t h e s t a r t i n g a m i n o a c i d i n a n h y d r o u s 
t e t r a h y d r o f u r a n o r d i e t h y l e t h e r . T h e s y n t h e s i s o f a l d e h y d e s b y L i A l H ^ 
r e d u c t i o n o f a m i d e s d e r i v e d f r o m N - m e t h y l a n i l i n e h a s b e e n r e p o r t e d t o 
g i v e g o o d r e s u l t s ( W e y g a n d e t a l . , 1 9 5 4 ) . C o n s e q u e n t l y , s y n t h e t i c e f f o r t s 
w e r e d i r e c t e d t o w a r d t h e p r e p a r a t i o n o f A c - A l a - P h e - N ( M e ) P h . A t t e m p t s t o 
c o u p l e t h e d i p e p t i d e a c i d , A c - A l a - P h e - O H , w i t h N - m e t h y l a n i l i n e u s i n g t h e 
d e h y d r a t i n g a g e n t d i c y c l o h e x y l c a r b o d i i m i d e ( D C C I ) r e s u l t e d i n t h e i s o l a ­
t i o n o f a r a c e m i z e d a m i d e p r o d u c t . V a r y i n g a m o u n t s o f r a c e m i z a t i o n a r e 
o f t e n o b s e r v e d i n DCCI c o u p l i n g r e a c t i o n s , a n d , i n t h o s e c a s e s w h e r e 
c e r t a i n N - a c y l a t e d p e p t i d e s a r e i n v o l v e d , c a n b e i d e n t i f i e d b y t h e n m r 
m e t h o d o f W e i n s t e i n a n d P r i c h a r d ( 1 9 7 2 ) . To c i r c u m v e n t t h i s p r o b l e m , a 
m i x e d - a n h y d r i d e p r o c e d u r e w a s e m p l o y e d t o p r e p a r e t h e o p t i c a l l y a c t i v e 
a m i d e . T h e r e q u i r e d s e q u e n c e o f r e a c t i o n s i s s h o w n i n F i g u r e 3 . 
N - a c e t y l - L - a l a n y l - L - p h e n y l a l a n i n a l w a s o b t a i n e d a s a c o l o r l e s s g l a s s 
a f t e r r e d u c i n g t h e N - m e t h y l a n i l i d e w i t h L i A l H ^ . T h e c o r r e s p o n d i n g p e p ­
t i d e a l c o h o l a n d a m i n e w e r e a l s o i s o l a t e d f r o m t h e r e a c t i o n m i x t u r e . A 
c r y s t a l l i n e s e m i c a r b a z o n e d e r i v a t i v e o f t h e a l d e h y d e w a s s y n t h e s i z e d a n d 
c h a r a c t e r i z e d . 
A l t h o u g h p e p t i d e a l d e h y d e s w e r e s p e c i f i c a l l y d e s i g n e d f o r u s e i n 
c r y s t a l l o g r a p h i c s t u d i e s w i t h c h y m o t r y p s i n A , i t s e e m e d r e a s o n a b l e t o 
s u p p o s e t h a t a l d e h y d e s i n g e n e r a l m i g h t b e u s e d t o p r o v i d e i n f o r m a t i o n 
Ac-Ala-OH Z-Phe-OH 
iBuOCOCl 





MeNC,Ho0 4 8 
Z-Phe-OCOOiBu 
C 6H 5NH(CH 3) 
Z-Phe-N(CH0)C,HC 
HBr/HOAc 
HBr-Phe-N(CH 3)C 6H 5 
Ac-Ala-Phe-N(CH3> C 6H 5 
1) LiAlH^ 
^ 2) NH 4C1 
Ac-Ala-Phe-H 
Peptide Aldehyde 
Figure 3. Reaction Scheme for a Synthetic Preparation 
Ac-Ala-Phe-H. 
39 
about the structure of the enzyme complex in solution. Consequently, 




V and VI, by slight modifications of published procedures (Israelashvili 
et al., 1951). Both naphthalene aldehydes were crystallized and character 
ized for further use. 
Kinetics of Inhibition 
The most appropriate parameter used to compare the relative bind­
ing strengths of the various competitive inhibitors is the dissociation 
constant, K . For competitive inhibition (eq. 7) the rate of reaction of 
+1 +S 
E-I * E E-S > E + P (7) 
-I 
enzyme and its substrate in the presence of an inhibitor is described 
by eq. 8 where K is the 
V S 
v M L ^ ( 8 ) 
m 
dissociation constant of the enzyme-inhibitor complex (eq. 9), K is 
m 
the Michaelis constant and V is the maximum initial velocity. 
max J 
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v = [E][I] ( 9 ) 
K I [E • I] ( 9 ) 
In this study the chymotrypsin or subtilisin catalyzed hydrolysis of 
Ac-Tyr-OEt is followed both in the absence and presence of inhibitors 
by means of an automatic pH-stat titrator, which adds base to titrate 
the acid formed as a product in order to maintain the pH constant at 
7.8 (eq. 10). 
0 0 || enzyme H 
CH.CONHCHCOC H + H o 0 > CH^CONHCHC 0 + H0C_H c + H + (10) 
3 I 2 5 2 P H 7.8 I 2 5 CRn pn /.o 
A strip chart recording was made of the volume of standard base added 
as a function of time, and this of course gave a direct measure of the 
rate of the reaction in question (Wilcox, 1970). These rates were then 
used to construct Eadie-Hofstee (v/s ys_ v) plots where v is the initial 
velocity of the Ac-Tyr-OEt hydrolysis and s is the substrate concentra­
tion. Of the various transformations of the Michaelis-Menten equation, 
this transformation has been shown to give more reliable results than 
the standard Lineweaver-Burke plot (Dowd and Riggs, 1965). The inhibi­
tion constants, K^, were determined by calculation from the y-intercepts 
of these plots according to the relationship given in eq. 11. For com­
parison purposes, accurate dissociation 
[y-intercept]j = [y-intercept] ^ 
1 + m K i 
d i ) 
41 
constants were also conveniently calculated from Dixon (1/v vs I) plots 
(Dixon, 1953) and found to give the same results. Typical data is shown 
is Figure 4. Table I presents the observed dissociation constants for 
chymotrypsin A binding of several aldehydes, alcohols and semicarbazones. 
Y 
Effectiveness of Chymotrypsin Inhibitors 
The experimental results indicate that our strategy was generally 
successful for designing aldehydes which would be excellent competitive 
inhibitors at pH 7.8 and 25.0°. The best inhibitor was the peptide alde­
hyde N-benzyloxycarbonyl-L-phenylalaninal (Z-Phe-H, III). Its observed 
dissociation constant, 7.8 x 10 ^ M, is indicative of a very strong 
enzyme-aldehyde complex, binding ca. 400-fold more tightly than the 
specific amide substrate Ac-Phe-NH 2 (VII) and CHO-Phe-NH(Et) (VIII). 
The magnitude of this dissociation 
0 0 0 0 ii 8 ii ii , 
CH'C NH CH C N H 0 HCNHCHCNH(CH CH ) 
3 i 2 I 
C H 2 C 6 H 5 C H 2 C 6 H 5 
VII VIII 
K =31mM(Himoe et al. , 1967) K = 20 mM(Fersht and Requena, 1971) 
S 
constant compares favorably with that found by Ito et al. (1972) for 
Ac-Leu-Leu-Phe-H (Kj = 5.2 x 10~ 5 M ) . 
The dipeptide aldehyde, Ac-Ala-Phe-H (II), was found to inhibit 
-4 
chymotrypsin with a value of 6.7 x 10 M. In contrast, a structurally 
similar inhibitor, Ac-Ala-NHCH.CH C-H C(K_ = 8.8mM) (Powers et al., 1974), 
2 Z o d I — — 
lacking the reactive aldehyde functional group, was observed to bind 1 3 
less effectively than II. Our dipeptide aldehyde, however, were not 
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Table 1. Observed Dissociation Constants for Chymotrypsin 
Ay-Binding of Aldehydes, Alcohols and 
Semicarbazones. a 
Inhibitor 
K , mM 
(Std. deviation) [I] range, mM 
Z-Phe-H 0.078 (.003) .03 - .05 
semicarbazone 0.68 (.02) .125- .50 
Z-phenylalaninol >5 .10 - .50 
Ac-Ala-Phe-H 0.67 (.03) .25 - 1.0 
semicarbazone 4.5 (0.3) 1.0 - 3.5 
Ac-Ala-Phenylalaninol >10 .10 - 1.0 
CHO-Phe-H ca. 8 1.0 - 5.0 
semicarbazone >50 1.0 - 5.0 
2 ~ C 1 0 H 7 C H = C H " C H ° 0.20 (.06) .05 - .075 
1-C 1 ( )H 7CH=CH-CH0 0.56 (.08) .10 - .25 
C,H cCH oCH„CH0 6 5 2 2 0.38 (.04) .25 - 1.0 
C.H cCH0 6 5 2.65 (.11) .5 - 2.0 
None 1.95 ( . 1 6 ) b , C 
5% (v/v) 1,2-dimethoxyethane, 0.10 F CaCl 2, pH 7.80, 25.0° 
for the hydrolysis of N-Acetyl-L-Tyrosine Ethyl Ester (Ac-Tyr-OEt) 
V = 371 ± 26 umoles substrate hydrolyzed/min/mg of enzyme. 
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as effective as the papain and elastase specific substrate aldehyde 
—7 —8 
analogs which had binding constants of 10 ~ 10 M. 
Formyl-L-phenylalaninal (IV) was observed to bind relatively poorly 
to ychy 0 1 0trypsin. Surprisingly, the K̂ . value found for the binding of 
CHO-Phe-H at pH 7.8 is only 2-4 times better than the binding constants found 
for the amides VII or VIII. On the other hand, our data indicate that both 
chromophoric aldehydes, V and VI, were effective, competitive inhibitors 
of chymotrypsin, binding 50 to 150 times more tightly than VII. 
Table I also includes apparent binding constants for a number of 
compounds related to our peptide aldehydes. These compounds, which 
include peptide semicarbazones and alcohols, were generally observed to 
be less tightly bound than the corresponding aldehydes. For example, the 
semicarbazone derivatives of Z-Phe-H and Ac-Ala-Phe-H were found to inhibit 
chymotrypsin approximately 7 to 9 times less effectively than their alde­
hyde counterparts. The analogous peptide alcohols, on the other hand, 
were not observed to inhibit chymotrypsin within the concentration limits 
of our experiments. 
Two additional aldehydes were reacted with chymotrypsin. Hydro-
cinnaldehyde (IX), whose 
C.H cCH oCH„CH0 C rH cCH0 o d Z Z o 5 
IX X 
Kj = 3.8 x 10" 4M K = 2.7 x 1 0 _ 3 M 
structure resembles hydrocinnamate ester and amide substrates, was 
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observed to effectively inhibit chymotrypsin at pH 7.8 and 250°. This 
behavior is consistent with previous binding studies of this aldehyde 
with chymotrypsin (Rawn and Lienhard, 1974; Schultz and Cheerva, 1975). 
In contrast, benzaldehyde ( x ) , lacking the ethylene bridge contained 
in hydrocinnamaldehyde, was a poorer chymotrypsin inhibitor, suggesting to us 
that X., although capable of binding in the enzyme's hydrophobic 
specificity pocket, may not react with the nucleophilic serine hydroxyl 
group. Hydrocinnamaldehyde, on the other hand, is 7 times more tightly 
bound to the enzyme. This observation is consistent with the additional 
formation of a reversible covalent bond between hydrocinnamaldehyde and 
Ser-195. 
It is informative at this point to question whether the free alde­
hydes or their hydrates are the inhibitory species. Several rapidly 
equilibrating enzyme-inhibitor complexes might conceivably account for 
the strong binding of our aldehydes. For example, it is possible that 
a stable noncovalent complex between the enzyme and the free aldehyde 
could occur. This situation, however, is considered unlikely. Since 
the aldehyde functional group is about the same size and shape as a pep­
tide bond, it is expected that the carbonyl group of an aldehyde should 
bind closely to the strongly nucleophilic hydroxyl group of Ser-195. 
Because aldehydes are quite susceptible to carbonyl addition reactions, 
this conjunction would be an unstable situation leading rapidly to hemi-
acetal formation formation. On the other hand, a noncovalent complex 
of chymotrypsin with an aldehyde hydrate is certainly conceivable. 
Such a complex would avoid placing a reactive carbonyl group 
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in the enzyme's active site. However, N-benzyloxycarbonylphenyl-
alaninol (XI) and N-acetyl-L-alanyl-L-phenylalaninol (XII), which 
might be considered reasonable analogs of the 






hydrated aldehydes, are extremely poor inhibitors. Furthermore, if 
noncovalent binding of an aldehyde hydrate to chymotrypsin is indeed 
the structure of the complex, it is difficult to see why aldehyde hydrates, 
which are gem-diols, should bind so much better than the analogous 
alcohols. Hydrogen bonds between the enzyme and a second hydroxyl group, 
should they exist, would not be likely to greatly favor the binding of a 
diol over the corresponding alcohol. Therefore, it is probable that 
the free aldehyde (rather than the gem-diol) is the inhibitory species, 
and the covalent tetrahedral hemiacetal (I) best represents the struc­
ture of the aldehyde-enzyme complex. 
To the extent that aldehyde hydrates are present in solution in 
equilibrium with the free aldehydes, apparent K̂ . values for the aldehydes 
in Table I are presumably higher than the true values. Thompson (1973) 
has shown that 
K_(obsd) = K (1 + K ) I I Hy 
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features of an aldehyde, this formation constant may equal that found 
for the hydration of acetaldehyde in water, i.e., = 1.4 (Bell, 
1966). Thus, the true value may be only 2.4 times smaller than K̂ . 
experimentally observed. 
Transition-State Analogs of Chymotrypsin 
The results described above would suggest that chymotrypsin-
aldehyde complexes might be considered transition state analogs 
for the enzymatic hydrolysis reaction. It has been forcibly argued that 
an enzyme will complex most tightly an activated form of its substrate 
and that such a complex would resemble the transition state for the 
reaction being catalyzed (Wolfenden, 1972). It is likely, therefore, 
that a particular substrate analog might also bind very tightly if its 
structure in the bound complex featured relevant elements of the cor­
responding substrate in its transition state complex. Because such an 
analog is predicted to be a powerful inhibitor, the dissociation con­
stant, Kj, may be used to estimate the degree to which this inhibitor-
enzyme complex resembles the true transition state. A good transition 
state analog would be expected to have a significantly lower than that 
of a comparable Michaelis complex. By this criterion, our aldehyde-
chymotrypsin complexes are possible transition state analogs since 
they have dissociation constants up to 400 times lower than observed K g 
values for comparable peptide amide substrates. As previously argued, 
the hemiacetal (I) is the most reasonable structure for the aldehyde-
chymotrypsin complex. Therefore, a plausible candidate for the transition 









tetrahedral adduct not very different from the proposed intermediate 
(XIII). 
Recently, alkylboronic acids, which readily form tetrahedral addi­
tion complexes, have been proposed as transition state analogs for 
a-chymotrypsin (Koehler and Lienhard, 1971; Rawn and Lienhard, 1974). 
Their very low dissociation constants were the first indication that 
they were bound at the enzyme active site as tetrahedral analogs of 
the transition state. This proposal has now been supported by X-ray 
crystallographic (Matthews et al., 1975) and laser Raman spectroscopic 
studies (Hess and Seybert, 1975). 
In addition to chymotrypsin, a number of other well-known pro­
teases possess a reactive serine residue important for catalytic activity. 
These serine proteases bear a surprising amount of structural and chemi­
cal similarities including crystal structure, active site geometry, 
extended binding site, amino acid sequence, catalytic mechanism, and 
biological function. Investigations have shown, however, that differ­
ences among the serine proteases arise principally from structural vari­
ations in substrate specificity. For example, the binding pocket in 
Effectiveness of Inhibitors with Subtilisin 
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subtilisin is more flexible and larger in size than the corresponding 
binding pocket in chymotrypsin (Kraut, 1971). Consequently, subtilisin 
manifests a broader substrate and inhibitor specificity at P^ (e.g. phe, 
leu, and lys). It seemed reasonable to suppose, therefore, that our 
aldehydes might be excellent competitive inhibitors of subtilisin. Of 
the three aldehydes tested (Z-Phe-H, Ac-Ala-Phe-H, and 2-C 1 0H 7CH=CH-CHO), 
only Ac-Ala-Phe-H was found to significantly inhibit subtilisin BPN 1. 
With an observed dissociation constant of 1.1 x 10 M, this aldehyde 
binds over 40 times more tightly than a dipeptide amide substrate such 
as Z-Ala-Leu-NH 2 (K g = 4.6 x 1 0 ~ 2 M) (Morihara et al., 1970). A 
detailed inhibition study with the other two aldehydes was difficult 
because of limited solubility. Negligibly small inhibition was observed 
in both cases. 
Ultraviolet Absorption Studies 
Having demonstrated that aldehydes were effective inhibitors of 
chymotrypsin, we rationalized that certain chromophoric analogs would 
strongly complex with the enzyme and be spectrally sensitive to chemical 
and physical effects of their environment. Consequently, we designed 
two reactive and intense ultraviolet-absorbing aldehydes which incorpora­
ted the structural features of extended naphthalene ir-resonance systems. 
These aldehydes were expected to complex with chymotrypsin so that the 
aldehyde functional groups were positioned near Ser-195 and the aromatic 
nucleus buried in the hydrophobic binding pocket (Figure 5 ) . It was 
anticipated that the intense it • it* transitions of these extended reso­
nance systems would occur at longer wavelengths and outside the absorption 
Figure 5. Schematic Representation of Possible Binding 
Interactions Between Two Chromophoric 
Aldehydes and the Chymotrypsin Active Site. 
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regions of the constituent tyrosine and tryptophan residues of the 
enzyme. It was hoped, moreover, that the interaction of these aldehydes 
with chymotrypsin would result in a derivative that would be suffi­
ciently stable to permit detection of any enzyme-hemiacetal intermediates. 
As previously described, both aldehydes did favorably inhibit chymotryp­
sin (Table I) and were observed to display absorption maxima outside the 
absorption regions of the enzyme. Unfortunately, significant changes in 
these absorption maxima were not observed when chymotrypsin was reacted 
with the inhibitors. New absorbances which might have been attributable 
to hemiacetal formation were not seen either. Small changes accompanying 
the binding of our aldehydes to the enzyme were difficult to precisely 
define under the conditions employed in our experiments. Perhaps compari­
sons between a totally inactive, but not denatured, enzyme might more 
easily establish the significance of any observed spectral changes. 
Although the binding of normal phenylalanine derivatives to the active 
site of chymotrypsin generally cause only small spectral changes to occur 
(Benmouyal and Trowbridge, 1966; Himoe et al., 1967), our results were 
disappointing since reports of unusual spectral perturbations have 
appeared in the literature when aroyl acylating agents were reacted with 
chymotrypsin (AA as large as 30 nm have been noted) (Charney and Bernhard, 
1967). 
X-ray Analysis of Inhibited Chymotrypsin A 
In both a and ychymotrypsins, considerable effort has been 
expended in the search for crystals of enzyme-substrate or enzyme-
inhibitor complexes which would be amenable to analysis using difference 
Fourier techniques. Chloromethyl ketone-A complexes, for example, have 
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been used in recent studies of the extended binding site of chymotrypsin 
(Segal, et̂  al., 1971a,b). The advantages of using irreversible inhibi­
tors such as chloromethyl ketones are two-fold: it makes possible the 
achievement of high occupancy at the binding site in the crystal, and 
it also permits straightforward characterization of the enzyme. In the 
present investigation, however, reversible aldehyde inhibitors were 
chosen for study. Although kinetic experiments showed that our aldehydes 
were excellent competitive inhibitors of chymotrypsin in solution, ana­
lytical methods were not available for testing the effectiveness of our 
compounds as inhibitors of the enzyme in the crystalline state. Conse­
quently, efforts were directed toward the collection and interpretation 
of diffraction date from zero-level precession photographs in order to 
characterize the inhibited enzymes. 
In Table II, the cell parameters of inhibited and native chymo­
trypsin crystals are presented. Inspection of the data will show that 
inhibition caused no changes in unit cell dimensions greater than 0.5%. 
Provided that Ay is truly inhibited, these results suggest that the 
native and derivative crystals are closely isomorphous. Nevertheless, 
obvious intensity differences were not noted when native and derivative 
photographs were visually compared. To circumvent this problem, statis­
tical comparisons of zero-level reflections (measured for Z-Phe-H 
inhibited and uninhibited A^ crystals) were attempted. The basis for 
comparisons were the fractional differences between derivative (1^) and 
scaled native (1^) reflection intensities, ^ • n ~ R I ^ / I D * T b e s c a l i n § factor, 
R = EI /EI , was required because the derivative reflections had been 
53 
Table 2. Unit Cell Dimensions of Native and 
Inhibited Crystals of Chymotrypsin A 
Space Group, P4 2 2) 
Inhibitor a = b (A) C(A) 
None a 69.3 97.4 
Z-Phe-H 69.0 98.0 
Ac-Ala-Phe-H 69.6 96.8 
Native crystals in 2.4 M phosphate, pH 5.6. 
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measured using longer exposure times. Fractional differences were calcu­
lated for each reflection and quantitatively compared with the standard 
derivation, a, calculated for the entire set of 572 reflections. Results 
indicate that 9 differences were above 3a, 22 were above 2a, and 99 were 
above la (a = 0 . 4 7 ) . These facts imply that the derivative and native 
crystals are probably distinct. Alternatively, the slightly misaligned 
zero-level native photograph may have elevated the calculated standard 
deviation. Because there were doubts that the direct difference Fourier 





In conclusion, we have succeeded in synthesizing three peptide 
aldehydes and related analogs, and have investigated their ability to 
generate suitable models of the tetrahedral transition state for chymo-
trypsin-catalyzed substrate hydrolysis. Kinetic studies show that 
the most effective competitive inhibitor of the group, N-benzyloxy-
carbonylphenylalaninal (Z-Phe-H, K̂ . = 7.8 x 10 M ) , binds to chymo­
trypsin about 400-fold more tightly than comparable amide substrates. 
Two other peptide aldehydes, acetylalanylphenylalaninal (Ac-Ala-Phe-H, 
K = 6.7 x 10 M) and formylphenylalaninal (CHO-Phe-H, K = 8 x 10 M) 
are observed to be less reactive. Only the dipeptide aldehyde, 
Ac-Ala-Phe-H, is seen to inhibit the homologous serine protease, subtili­
sin BPN'. In addition to our peptide aldehydes, two intensely chromo-
phoric analogs were also synthesized and are seen to be excellent com­
petitive inhibitors of chymotrypsin. Nevertheless, significant 
spectral perturbations are not observed when either aldehyde complex is 
formed. Results of our x-ray crystallographic studies, however, sug­
gest that both Z-Phe-H and Ac-Ala-Phe-H inhibit crystals of chymotrypsin 
A^ without causing significant changes in unit cell dimensions. Other 
kinetic data indicate that semicarbazone derivatives of our peptide 
aldehydes compete just 7 - 9 times less effectively in chymotrypsin 
inhibition experiments than the corresponding aldehydes, but that 
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peptide alcohols are quite unreactive. 
It is now generally accepted that the transition state for sub­
strate hydrolysis by serine proteases closely resembles a tetrahedral 
intermediate in which the catalytic serine hydroxyl group forms a 
covalent adduct with the carbonyl carbon of the labile bond. On the 
basis of the kinetic results presented here, together with data from 
other investigators, we suggest that our aldehydes reversibly bind to 
chymotrypsin as covalent tetrahedral hemiacetals, and that these enzyme-
aldehyde complexes are stereochemically analogous to the tetrahedral 
transition state for the hydrolysis reaction. Direct evidence for the 





A worthwhile extension of the work reported herein might be a 
kinetic and crystallographic investigation of the S 1 binding subsites 
of chymotrypsin and related proteases using peptide aldehyde imines. 
S f binding subsites may be defined as those subsites on the enzyme sur­
face which interact with extended peptide substrates on the nitrogen 
side of the scissionable peptide bond (Figure 6). S binding subsites 
on the other hand, interact with residues on the carbonyl side of the 
peptide bond which is cleaved. Imines may be synthesized by coupling a 
peptide aldehyde with an appropriate amine. Competitive inhibition 
studies as well as difference Fourier studies could be utilized to eluci­
date the number and character of the S f binding subsites. Such studies 
would complement those which have already yielded considerable informa­
tion on the S binding subsites of serine proteases. 
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- CO J- Y 
Normal Peptide Substrate 
X - NH - CH - C = N - CH - CO - NH - CH - CO - Y 
R. H R, R, 
Imine of a Peptide Aldehyde 
Note: Amino acid residues, P-, p', and p' are located at subsites i i 1 1 z S^, S^, and S^, respectively. Normal substrate cleavage occurs 
between residues P^ and P^. This scheme was originally proposed 
by Schecter and Berger (1967). 
Figure 6. Scheme for Depicting the Positioning of 
a Polypeptide Substrate and an Imine of 
a Peptide Aldehyde in the Binding Site 
of a Protease. 
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PART II 
INHIBITION OF ELASTASE BY 




Pulmonary emphysema is believed to result from the uninhibited 
proteolysis of elastic lung tissue by elastase and related neutral 
proteases derived from leukocytes and macrophages (Mittman, 1 9 7 2 ) . 
Normally, the lungs are protected from proteolytic digestion during 
infection or inflammation by the protease inhibitor a^-antitrypsin. 
Individuals with a deficiency of a^-antitrypsin, however, are biased 
toward chronic pulmonary lung diseases. The development of appropriate 
synthetic inhibitors, sufficiently reactive and specific, and capable 
of replacing ct^-antitrypsin, might therefore prove to be valuable 
reagents for the treatment of emphysema, arteritis, arthritis and related 
diseases. In addition, these elastase inhibitors would be important and 
r e l e v a n t reagents for the s t u d y of t h e biological f u n c t i o n of e l a s t o -
lytic enzymes. This thesis, Part II, reports the synthesis and reac­
tivity o f several tetrapeptide chloromethyl ketones which are both 
reactive and selective elastase inhibitors. 
Background 
Elastase, like chymotrypsin and trypsin, is a serine protease, 
and most characterization studies have been carried out on the readily 
available porcine pancreatic enzyme (EC. 3 . 4 . 2 1 . 1 1 ) . Its inactive 
precursor, proelastase, is secreted by the pancreas and converted to 
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active enzyme just before use by another enzyme, trypsin. Elastase 
has a molecular weight of approximately 25,900, consists of a single 
polypeptide chain 240 amino acids in length, and contains 4 disulfide 
bonds (Hartley and Shotton, 1971). The active-site residues essential 
for catalytic activity have been identified to be Ser-188 and His-45. 
Optimal activity occurs at pH 8.5. The detailed molecular structures of 
tosyl elastase and native elastase have been determined from 3.5 A 
electron density maps and correlate well with solution kinetic proper­
ties (Shotton and Watson, 1970; Shotton, et al., 1971). A charge-relay 
mechanism of elastase catalysis has been proposed, identical with that 
for chymotrypsin (Hess, 1971; Hartley and Shotton, 1971). Elastase 
differs from other serine proteases chiefly in substrate specificity: 
substrates with uncharged nonaromatic side chains, e.g. alanine and 
valine, are preferred because the entrance to the specificity pocket 
is blocked by residues Val-216 and Thr-226. Both are glycyl residues in 
chymotrypsin. Like the other serine proteases, however, elastase is an 
endopeptidase and shows esterase activity toward synthetic substrates 
such as Ac-Ala-Ala-Ala-OCH^. Unlike them, the reactivity of elastase is 
very dependent on the peptide length of substrates or inhibitors. 
A number of proteolytic enzymes are known to occur in human 
polymorphonuclear (PMN) leukocyte granule fractions, including an elas­
tase which is active at physiological pH(7-8). This human leukocyte 
elastase has recently been purified by affinity chromatography and par­
tially characterized (Janoff and Scherer, 1968; Janoff, 1973; Folds 
et al., 1972; Ohlsson and Olsson, 1973). It is known to degrade human 
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lung elastin, arterial walls and basement membrane, digest proteins 
of bacteria cell walls in vitro, induce cellular surface changes 
associated with loss of growth control, and undergo inhibition by 
a^-antitrypsin and peptide chloromethyl ketones (Janoff et al., 1972; 
Janoff and Blondin, 1973, 1974; Mosser et al., 1973; Janoff, 1972b). 
Experimental evidence has suggested, furthermore, that human leukocyte 
elastase may be involved in pathological processes associated with 
elastic tissue damage in acute arthritis, pulmonary emphysema, and 
with the tumor-producing action of co-carcinogenic substances (Janoff, 
1972a,b; Galdston et al., 1973; Mittman, 1972). Like the more widely 
studied porcine pancreatic elastase, human leukocyte elastase is a 
serine protease and exhibits esterase activity toward synthetic sub­
strates such as Boc-Ala-ONp and Ac-Ala-Ala-Ala-OCH^. 
Although a variety of synthetic inhibitors are known to react 
with elastase, certain peptide chloromethyl ketones have received much 
recent attention (Powers and Tuhy, 1972, 1973; Tuhy and Powers, 1975; 
Thompson and Blout, 1973a; Thomson and Deniss, 1973). Chloromethyl 
ketones form a broad class of inhibitors and have been immensely useful 
for studying proteolytic enzymes (Shaw, 1970). If properly designed to 
resemble natural substrates, chloromethyl ketones can be made fairly 
specific for one serine protease or a group of serine proteases with 
similar specificity. The reason for the specificity of chloromethyl 
ketones is apparent upon consideration of the mechanism of action of 
serine proteases. 
As revealed by X-ray crystallographic investigations, the cata­
lytic centers of the serine proteases chymotrypsin, subtilisin, trypsin 
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and elastase are essentially identical in composition and conformation, 
all containing a charge-relay system composed of an activated serine, 
a histidine, and an aspartic acid residue (Hess, 1971; Blow et al., 
1969). Furthermore, each enzyme contains a binding pocket adjacent to 
the catalytic residues whose size and chemistry determine the primary 
substrate specificity. When a substrate properly binds to the enzyme, 
the carbonyl group of the scissile peptide bond is oriented in such a 
way that attack by the active-site serine residue can occur, thus lead­
ing to the formation of an acyl enzyme intermediate which rapidly turns 
over (Figure 1 ) . A similarly bound chloromethyl ketone, however, would 
place the chloroketone moiety adjacent to the imidazole ring of the 
active-site histidine residue. Irreversible alkylation via formation 
of a covalent bond between histidine and inhibitor would then occur. 
The binding modes of peptide chloromethyl ketones with chymotrypsin A^ 
(Segal et al., 1971a, b) and subtilisin-BPN 1 (Robertus et al., 1972; 
Kraut et al., 1971, 1975; Poulas et al., 1975) have recently been inves­
tigated by X-ray crystallography. These enzyme-inhibitor interactions 
are illustrated in Figures 2 and 3. The phenyl group of chloromethyl 
ketones was found to be located in the hydrophobic binding pocket, and 
the peptide chain of an extended inhibitor and a section of the backbone 
of the enzyme formed a 3-sheet structure. The solution inhibition 
kinetics of these two proteolytic enzymes have also been studied 
(Kurachi ê t al., 1973; J. C. Powers and J. T. Tippett, unpublished 
observations). In general, the greater the enzyme-inhibitor interaction, 
at the primary as well as the extended binding site, the better the 
inhibition. 
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Figure 1. A Schematic Representation of Pancreatic Elastase 
Reactions with Substrates and Peptide Chloromethyl 
Ketone Inhibitors. 
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Figure 2. Illustration Showing the Proposed Binding 
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Note: Chymotrypsin (below) and the inhibitor Z-Ala-Leu-Phe-Q^Cl 
(above) form an anti-parallel 3-pleated sheet structure 
involving three hydrogen bonds. 
Figure 3. Diagram of Chymotrypsin A Showing the 
Extended Binding Site Region. 
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Recently, a series of P^-alanine peptide chloromethyl ketones 
have been demonstrated to be fairly reactive and specific inhibitors 
for porcine pancreatic elastase and human leukocyte elastase (Powers 
and Tuhy, 1972, 1973; Tuhy and Powers, 1975). These studies defined 
two important structural features as being necessary for developing an 
optimally reactive and selective elastase inhibitor. First, the com­
pounds should contain a terminal alanine chloromethyl ketone moiety 
because elastase has demonstrated a primary specificity for alanine 
residues (Narayanan and Anwar, 1969; Atlas et̂  al., 1970; Geneste and 
Bender, 1969; Kaplan et al., 1970; Atlas and Berger, 1972). Second, 
the inhibitors should contain an extended peptide chain since the rate 
of substrate hydrolysis is known to be strongly dependent on chain length 
(Atlas et al., 1970; Atlas and Berger, 1972; Thompson and Blout, 1970, 
1973b). This very important feature was shown to enhance inhibitor 
reactivity, presumably through an increased interaction with the extended 
binding site of elastase. 
Rationale for Development of Elastase Inhibitors 
A recent computer study has examined the bonds split by porcine 
pancreatic elastase in a sampling of polypeptide substrates (Whitley, 
ejt al., 1975). Significant correlations were made concerning the amino 
acids adjacent to the cleaved peptide bonds. Elastase had been thought 
to exhibit distinctive substrate or inhibitor specificity for alanine 
residues at P^ subsites. Surprisingly, the probabilities of peptide 
bond cleavages after valine (42.9%) and isoleucine (41.7%) residues 
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were higher than that for alanine (37.1%). In addition, a 29.2% cleav­
age probability was noted for P^-threonine residues. These results 
suggested that chloromethyl ketones which incorporated the structural 
features of an extended peptide chain and an isoleucine, valine or 
threonine at the P^ position should be synthesized and compared with the 




Materials and Methods 
Porcine pancreatic elastase (lot 55B405) was obtained from Whatman 
Biochemicals Ltd.and used without further purification; its substrate, 
Boc-Ala-ONp, was purchased from Sigma Chemical Co. Human leukocyte 
elastase was gratuitously provided by Dr. Aaron Janoff at S.U.N.Y. at 
Stony Brook; it was 95% pure as determined by a gel densitometry scan. 
Chymotrypsin A^ (lot CDIOBK) was obtained from Worthington Biochemical 
Co., and its substrate, Ac-Tyr-OEt, was synthesized in our laboratory 
and had mp 80-81°. Trypsin (lot 102C-1920) and its substrate, Bz-Arg-
OEt, were obtained from Sigma Chemical Co. The tripeptide ester, 
Ac-Ala-Ala-Pro-OBz, and the tetrapeptide chloromethyl ketone, 
Ac-Ala-Ala-Pro-Ala-C^Cl, were synthesized by Dr. R. Boone. N-t-Butyl-
oxycarbonyl-L-valine (Boc-Val-OH) was prepared from valine and t-Butyl-
azidoformate using the pH-stat method (Schnabel, 1967), mp 73-75°(lit: 
72). Boc-L-isoleucine *l/2 ^ 0 and Boc-L-threonine were purchased from 
Bachem, Inc. and dried under vacuum overnight. All other reagents and 
solvents were analytical grade. Thin-layer chromotography was performed 
using Merck silica gel G plates. Elastase inhibition kinetics were 
performed on a Beckman Model 25 spectrophotometer. Chymotrypsin and 
trypsin inhibition kinetics were performed on a Radiometer automated 
pH-stat (model TTTII). Mass spectra were taken on a Hitachi Perkin-
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Elmer RMU-7C instrument using a 70 electron volt source, and nuclear 
magnetic resonance (nmr) spectra were taken on a Varian T-60 instru­
ment. The peak positions in the nmr spectra are reported in ppm rela­
tive to tetramethylsilane. The following abbreviations are used: s, 
singlet; d, doublet; t, triplet; m, multiplet; b, broad. 
L-Valine Chloromethyl Ketone Hydrochloride (HC1*Val-CH 2C1) 
The diazo ketone Boc-Val-CHN^ was prepared from Boc-Val-0H(10.0 gm, 
45 mmol) and diazomethane using a mixed anhydride method (Penke et al., 
1970). Anhydrous HC1 was bubbled through a solution of Boc-Val-CHN 2 
in ether/tetrahydrofuran at 5°C for 15 minutes as the solution turned 
from yellow to colorless. The product was isolated, recrystallized 
from THF/Et^O and dried in vacuo to give 4.5 gram (55%) of an extremely 
hygroscopic white solid. 
N-Acetyl-L-Alanyl-L-Prolyl-L-Valine Chloromethyl Ketone 
Ac-Ala-Ala-Pro-Val-CH 2Cl was prepared from deblocked Ac-Ala-Ala-
Pro-OBz and HC1*Val-CH^Cl using a mixed anhydride coupling method 
(Anderson et al., 1967). Ac-Ala-Ala-Pro-OH (1.5 g, 5 mmol) was dis­
solved in 50 ml anhydrous tetrahydrofuran and stirred at -15°C while 
N-methylmorpholine (.55 ml, 5ramol) and isobutyl chloroformate (.65 ml, 
5 mmol) were added. After 10 minutes, the N-methylmorpholine salts were 
filtered and HC1.Val-CH 2C1 (.93 g, 5 mmol in 5 ml DMF) and N-methyl­
morpholine (.55 ml, 5 mmol) were added. Stirring was continued for 4 
hours as the mixture warmed to 25°C. Then the solvent was removed in 
vacuo and the resulting yellow oil was dissolved in methanol and 
chromatographed on Merck silica gel G 0.063-0.2 mm. The product was 
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isolated after elution with 8% methanol in chloroform. Recrystalliza-
o 
tion from methanol gave 1.05 g (49%) of a white solid, mp 195-196 (d), 
R f 0.41 (CHC1 3-CH 30H, 9:1). The nmr spectrum (CDC1 3) showed peaks at 
8.23 (1H, d, NH), 7 70 (lH,d,NH), 6.43 (1H, d, NH), 4.77 (4H, m, NHCH 
(R)C0), 4.23 (2H, s, COCH^Cl), 3.70 (2H, b, N-CH^-(CH 2) 2~CH), 
2.10 (5H, m, C H ( C H 3 ) 2 and N-CH 2-(CH 2) 2CH), 2.03 (3H, s, CH^CO), 
1.27 (6H, m, C H ( C H 3 ) 2 ) , and 0.87 (6H, m, CH(CH 3)C0). 
The mass spectrum showed major peaks at m/e 430 (M+), 395(M-C1), 
353(Ac-Ala-Ala-Pro-NHCH(CH(CH 3) 2)+) , 282(Ac-Ala-Ala-Pro+) , 
254 (Ac-Ala-Ala-'N- (CH 2) 3CH+) , 238((Ala-Ala-Pro+)-H) , 185 (Ac-Ala-Ala+) , 
167((Ala-Pro+)-H), and 114 (Ac-Ala+) . 
Anal. Calcd for C H ^ N ^ C l : C, 52.96; H, 7.20; N, 13.00. 
Found: C, 52.67; H, 7.30; N, 12.96 
N-Acetyl-L-Alanyl-Alanyl-L-Prolyl-L-Isoleucine Chloromethyl Ketone 
Ac-Ala-Ala-Pro-Ile-CH 2Cl was prepared similarly to Ac-Ala-Ala-Pro-
Val-CH 2C1 from Ac-Ala-Ala-Pro-Ala-OH and HC1 Ile-CH 2C1 (prepared analo­
gously to HC1*Val-CH 2C1). The product was isolated from the residue 
by chromatography on a silica gel column from which it was eluted with 
7% methanol in chloroform. Recrystallization from methanol gave 1.21 g 
(55%) of a white solid, mp 207-208° (d), R f 0.49(CHCl^CH^H, 9:1). 
The nmr spectrum (CDC1 3) showed peaks at 68.27 (1H, d, N H ) , 
7.77 (1H, d, NH), 6.57 (1H, d, NH), 4.77 (4H, m, NHCH(R)CO), 
4.27 (2H, s, COCH^Cl), 3.70 (2H, b, h - C H ^ C H ^ - C H ) , 
2.13 (5H, m, CH(CH(CH 3)CH 2CH 3)C0 and fo-CH^(Cjy 2 " C H ) , 1.99 (3H,s,CH 3C0) , 
1.27 (8H, m, CH(CH 3)C0 and CH(CH(CH 3)CH 2CH 3)C0), and 0.90(6H,m,CH(CH(CH 3) 
CH 2CH 3)C0). 
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The mass spectrum showed major peaks at m/e 444 (M+), 
367(Ac-Ala-Ala-Pro-NH(CH(CH 3)CH 2CH 3)+), 282(Ac-Ala-Ala-Pro+), 
254(Ac-Ala-Ala-ft-(CH 2) 3CH+), 185(Ac-Ala-Ala+), 167((Ala-Pro+)-H), 
and 114(Ac-Ala+). 
Anal. Calcd for C ^ H ^ N ^ C l : C, 53.99; H, 7.42; N, 12.60. 
Found: C, 53.90; H, 7.54; N, 12.61. 
N-Acetyl-L-Alanyl-L-Alanyl-L-Prolyl-L-Threonine Chloromethyl Ketone 
^c-Ala-Ala-Pro-Thr-CH 2Cl was synthesized from Ac-Ala-Ala-Pro-OH 
and HCl*Thr-CH 2Cl. L-Threonine chloromethyl ketone hydrochloride was 
prepared similarly to HCl*Val-CH 2Cl; in this case the product was 
isolated as an oil and immediately dissolved in 5 ml dimethylformamide 
(DMF) for use in a subsequent coupling reaction. Ac-Ala-Ala-Pro-OH 
(.75 g, 2.5mmol) was dissolved in 50 ml dry tetrahydrofuran and stirred 
at -15°C while N-methylmorpholine (.28 ml, 2.5mmol) and isobutyl chloro-
formate (.33 ml, 2.5mmol) were added. After 10 minutes, the solution 
was filtered and HC1*Thr-CR^Cl (.43 g, 2.5mmol) and N-methylmorpholine 
(.28 ml, 2.5 mmol) were added. After stirring 4 hours at 25°C, the 
solvent was removed in vacuo and the resulting oil chromatographed on 
a silica gel column. The product was isolated after elution with 9% 
methanol in chloroform. Recrystallization from ethyl acetate-methanol 
(100:1) gave .21 g (19%) of a white solid, mp 200-201° (d), R f 0.28 
(CHC± 3-CH 30H, 9:1). The nmr spectrum (CDC1 3) showed peaks at 
68.07(1H, d, NH),7.67(1H, d, NH), 6.37(1H, d, NH), 4.70(4H, m, CH(R)CO), 
4.30(2H, s, C0CH 2C1), 3.70(3H, s, h - C H 2 ( C H ^ - C H and CH(0H)CH 3), 
3.10(1H, d, CH(0H)CH 3), 2.13(4H, m, N-CH^(CH 2) 2~CH)), 1.97(3H, s, CH CO) 
and 1.20(9H, m, CH(CH_ 3)). 
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The mass spectrum showed major peaks at m/e 414(M-H 20), 397(M-C1), 
378(M-H 20-C1), 311(Ac-Ala-Ala-Pro-NHCH 2+), 282(Ac-Ala-Ala-Pro+), 
254(Ac-Ala-Ala-N-(CH 2) 3CH+), 185(Ac-Ala-Ala+), 168(Ala-Pro+), and 
114(Ac-Ala+); no M+ peak was observed. 
Anal. Calcd for C- 0H 0 0N,0,C1: C, 49.94; H, 6.71; N, 12.95 
~ lo Zy h O 
Found: C, 49.91; H, 6.76; N, 12.89. 
Reaction of Porcine Pancreatic Elastase with Inhibitors 
Inhibition of porcine pancreatic elastase with the series of 
tetrapeptide chloromethyl ketones was carried out under pseudo-first-
order conditions in solutions which contained at least a ten-fold excess 
of inhibitor over enzyme. Residual enzymatic activity was measured 
periodically using the Boc-Ala-ONp spectrophotometric assay (Visser and 
Blout, 1972). A stock solution of elastase prepared in 1 mM HC1 was 
stored at 4°C and had a concentration of 9.4 yM or 0.24 mg/ml by uv 
absorbance. Inhibitor solutions (.10 mM or 10.0 mM) were prepared by 
dissolving a weighed amount of inhibitor in methanol and diluting with 
pH 5.0 buffer (.1 M acetate) resulting in a 10% methanol solution. 
The inhibition reaction was started by mixing 0.5 ml of the inhibi­
tor solution with 0.5 ml of the enzyme solution at 30.0°C and proceeding 
through at least two half lives. Initial concentrations (total volume 
of 1.0 ml) were as follows: inhibitor, 0.05 or 5.0 mM; elastase, 4.8 yM; 
methanol, 5% (v/v). The reaction was monitored by removing 6-8 aliquots 
(100 yl each) from the inhibition solution at periodic time intervals 
and rapidly mixing with 2.0 ml of a 0.2 mM Boc-Ala-ONp substrate solu­
tion in a sample cuvette. The substrate solution was buffered at pH 6.5 
(0.5 M phosphate) and contained 2% (v/v) CH„CN. The release of 
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p-nitrophenol was followed at 347.5 nra for 1.0-1.5 minutes on the uv 
spectrophotometer. The active elastase concentration did not decrease 
more than 2% in 1 hour as indicated by control runs which lacked only 
inhibitor. 
For each inhibition reaction the kinetic parameters k , , a n d 
r obsd 
k. , = k . j/[I] were calculated from eq. 1 2nd obsd n 
v = kobsdt E] ^ n d " ^ ( 1 ) 
using a least squares computer program. Correlation coefficients of 
better than 0.995 were maintained throughout for the linear plots. 
Reaction of Human Leukocyte Elastase with Inhibitors 
Inhibition experiments with leukocyte elastase were carried out 
under conditions which minimized the enzyme consumed yet facilitated 
kinetic measurements. In all inhibition reactions, the final concentra­
tion of inhibitor was at least 5-fold greater than the enzyme concentra­
tion. Inhibitor solutions were buffered at pH 6.5 (.1 M phosphate) and 
contained 10% (v/v) methanol. Elastase solutions (ca 0.50 mg/ml) were 
prepared by dissolving a weighed amount of lyophilized enzyme in 
.1 M phosphate buffer (pH 6.5). The inhibition reaction was started by 
mixing 0.025 ml of the inhibitor solution with 0.030 ml of the enzyme 
at30°C, and proceeding through at least two half-lives. Initial concen­
trations (total volume of 0.055 ml) were: elastase, 10 yM; tetrapeptide 
inhibitor, 0.05, 0.20, 0.40 or 10.0 mM; NaCl, 0.06 M; methanol, 5% (v/v). 
Enzyme assays were performed by removing 10 yl aliquots at periodic time 
intervals and rapidly mixing with 0.25 ml of a 0.2 mM Boc-Ala-ON^ sub­
strate solution in a microcuvette. Kinetic analysis were performed as 
before. 
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Reaction of Chymotrypsin and Trypsin with Inhibitors 
Inhibition experiments with chymotrypsin and trypsin were carried 
out under conditions virtually identical with those employed in the 
inhibition reactions with human leukocyte elastase. All inhibition 
reactions were carried out at 30.0° and pH 6.5 Stock solutions of enzymes 
and inhibitors were prepared at appropriate concentrations and used 
quickly. Enzyme concentrations were determined by ultraviolet absorbance. 
A typical inhibition reaction was started by mixing 0.25 ml of the inhibi­
tor solution, 0.25 ml of methanol, 0.5 ml of the enzyme solution, and 9 
ml of .1 F_ citrate buffer (pH 6.5) and proceeding for 0-4 hours. Ini­
tial concentrations were as follows: enzyme, 10 jjM; inhibitor, 0.5 mM -
10.0 mM; and methanol, 5% (v/v). 
At various time intervals, an aliquot (100 yl) was removed from 
the inhibition mixture and assayed for residual enzyme activity using 
a Radiometer automated pH-stat to measure the initial hydrolysis rate 
of substrate at pH 7.8. Chymotrypsin was assayed using .01 F_ N-acetyl-
L-tyrosine ethyl ester (Ac-Tyr-OEt) as the substrate and 0.5420 _F NaOH 
as the titrant. The substrate solution contained 0.1 F CaCl^ and 
5% (v/v) methanol. Initial velocities were obtained from the pH-stat 
recorder tracings of base consumption with respect to time using the 
method of Henderson (1971). Kinetic analyses were performed as pre­
viously described for elastase. Correlation coefficients of better than 
0.991 were obtained throughout. 
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CHAPTER III 
RESULTS AND DISCUSSION 
Three peptide chloromethyl ketones were synthesized and tested as 
inhibitors of porcine pancreatic elastase and human leukocyte elastase. 
By regularly varying the P-̂  residues of the inhibitors, the enzyme's 
primary specificity was studied in an effort to design an optimum elas­
tase inhibitor having a maximum velocity. 
Synthesis of the Inhibitors 
A series of three tetrapeptide chloromethyl ketones were prepared 
using a mixed anhydride method. The final steps used in preparing a 
typical inhibitor, Ac-Ala-Ala-Pro-Val-CH^Cl, are shown in Figure 4. 
The exemplary structure of this inhibitor as well as a description of 
the notation adopted for describing its alignment in the binding site 
of elastase are presented in Figure 5. 
All of the peptide chloromethyl ketones were relatively easy to 
prepare and handle. Minor difficulties, however, were encountered with 
the unstable L-threonine chloromethyl ketone hydrochloride intermediate. 
This compound could not be crystallized but was immediately used in a 
subsequent coupling reaction. Although the desired coupling reaction 
was apparently achieved, the fact that the isolation of the product 
occurred in only 19% yield is presumably explicable on the basis of 













MeNC.Ho0 4 8 
Ac-Ala-Ala-Pro-Val-CH2Cl 
Tetrapeptide Chloromethyl Ketone 
Figure 4. Final Synthetic Steps Used in the Preparation of 
Ac-Ala-Ala-Pro-Val-CH0C1. 
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Ac Ala Ala Pro Val CH 2 - CI 
Note: The residues P^ - P^ are designated according to the notation 
of Schechter and Berger (1967). 
Figure 5. Structure of the Typical Peptide Chloromethyl 
Ketone Ac-Ala-Ala-Pro-Val-CH 0C1. 
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Tetrapeptide chloromethyl ketones were found to be stable in the solid 
state but to undergo slow hydrolysis in aqueous solution. 
Kinetics of Inhibition 
The irreversible reaction of an active-site-directed inhibitor 
with an enzyme may be represented by eq. 2 and 3 
K k I ̂  k 3 
E + I ̂ = E-I > E-I (2) 
K = [E][I] ( 3 ) 
K I [E-I] U ) 
where E*I represents a noncovalently bound complex of the enzyme with 
the inhibitor, E-I is the final product with the inhibitor irreversibly 
bound to the enzyme via a covalent linkage, K̂ . is the dissociation con­
stant of the E*I complex, and k^ is the limiting rate of inactivation. 
If the inhibitor concentration is sufficiently great, then the decrease 
in the total enzyme concentration (E + E*I) in the inhibition reaction 
follows pseudo-first-order kinetics at any fixed value of [I]. In 
this case, the observed first-order rate constant can be represented by 
eq. (4) 
k 3 m 
kobsd = Kj + [I] ( 4 ) 
(Kitz and Wilson, 1962, Kurachi et al., 1973). 
If the chosen inhibitor concentration is approximately equal to 
K T(I = K_), then the ratio k , ,/[I] will vary over a range of inhibitor 1 l obsd 
concentrations and both K̂ . and k^ can be evaluated. If, on the other 
hand, the value of K^ should be much greater than the chosen inhibitor 
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concentration (K^ > I ) , then eq. (4) reduces to eq. (5) 
kpbsd _ ^3 ,r\ 
[I] Kj. W 
and the inhibition parameter, k^/K^., comparable to a second-order rate 
constant (K^nd^' C a n b e determined. 
The reactivity of a series of related inhibitors can be compared 
on the basis of their relative k , ,/[I] values. The differences in 
obsd 
these k , ,/[I] values will thus reflect both the effect of structural obsd 
changes upon binding of inhibitor to enzyme as well as the rate of reac­
tion within the E*I complex. ^ Q b s d ^ ^ v a ^ - u e s » however, are subject to 
distortion from nonlinear concentration effects when [I] = K^. 
Elastase Inhibition Studies 
The series of peptide chloromethyl ketones generally acted as 
highly reactive irreversible inhibitors of porcine pancreatic and 
human leukocyte elastase. Kinetic results for the porcine pancreatic 
enzyme are presented in Table 1 and for the human leukocyte enzyme in 
Table 2. Relative values of k , n/[I] were calculated and are the basis 
obsd 
for reactivity comparisons. Reaction conditions were selected in order 
to obtain feasible reaction rates. Both the inhibitor concentration 
and pH were decreased to practicable levels so that rates could be 
accurately measured. Although optimal elastase activity occurs at pH 
8.5, rapid inhibition occurred even at pH 5.0. Good pseudo-first-order 
kinetics were observed in all cases. The specific activity of the 
enzyme, expressed as Aabs./min./yg enzyme, was .032 in the 2.1 ml 
Table 1. Inhibition of Porcine Elastase with Tetrapeptide Chloromethyl Ketones. 
Inhibitor 
P P P P 4 / 3 2 1 
[I] x 10 , M 
m 4 i b -1 10 k , ,, sec obsd 
(Std. dev.) Half-life, min 
k 0 b 8 d / [ I ] 
M - l "I 
M sec 
(rel. values) 
Ac-Ala-Ala-Pro-Ile-CH 2Cl 0.5 24 (.96) 4.8 48 (1.2) 
Ac-Ala-Ala-Pro-Val-CH 2Cl 0.5 18 (.38) 6.7 35 (0.9) 
Ac-Ala-Ala-Pro-Ala-CH 2C1 0.5 20 (.77) 5.8 40 (1.0) 
Ac-Ala-Ala-Pro-Thr-CH 2C1 50.0 4.1 (.11) 27.9 .08 (.002) 
Elastase concentration 5 yM, at pH 5.0, 30°C, 5% (v/v) methanol. 
Average of three runs. 
Table 2. Inhibition of Human Leukocyte Elastase with Tetrapeptide Chloromethyl Ketones. 
Inhibitor 
P P P P 4 3 2 1 
[I] x 10 , M 




k o b s d / [ I ] 
M - l -1 M sec 
(rel. values) 
























Elastase concentration 10 uM, at pH 6.5, 30°C, 5% (v/v) methanol. 
Average of three runs. 
'Average of two runs. 
87 
porcine pancreatic elastase assay and .020 in the .26 ml human leukocyte 
elastase assay. Because the peptide chloromethyl ketones hydrolyzed 
slowly in buffered aqueous solution, the inhibition solutions were 
always freshly prepared. Just enough methanol (5%, v/v) was added to 
solubilize the inhibitors at 30°C. In all experiments, the reaction was 
allowed to proceed through at least two half-lives. No direct evi­
dence was produced to indicate that peptide chloromethyl ketones 
actually reacted with the active site histidine residue of elastase 
(His-45). By analogy with related serine proteases, it is almost cer­
tain that histidine alkylation does take place. That peptide chloromethyl 
ketone elastase inhibitors do indeed react with a histidine residue has 
been verified by Thompson and Blout (1973a). 
Effectiveness of Porcine Pancreatic Elastase Inhibitors 
The overall rate of an active-site-directed irreversible inhibitor 
depends both on the amount of E»I complex present at equilibrium as well 
as the rate-limiting reaction of the bound inhibitor with the enzyme 
to form the inactivated enzyme (E- I). Covalent bond formation would 
certainly be influenced by the steric arrangement of the inhibitor 
with enzyme in the E»I complex and by electronic effects. On the other 
hand, the dissociation constant, K^.,of the E»I complex is determined 
primarily by the increase in entropy upon binding the inhibitor to the 
enzyme. This increase is due presumably to the disruption of water 
structure. Obviously, a structural change in the inhibitor could 
affect both the extent of binding to the enzyme, measured by K , or the 
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stereoelectronic relationship between the inhibitor and enzyme in the 
E-I complex, measured by k^. That the affinity of an inhibitor for an 
enzyme is not necessarily related to the rapidity of inactivation has 
been shown by Shaw and Glover (1970). Due to the generally low inhibitor 
concentrations used, these two effects were not separately evaluated in 
the present study. Instead, a comparison of the effectiveness of the 
tetrapeptide chloromethyl ketone inhibitors was based on their relative 
k Qk g^/[I] values, thus reflecting both the influence of and k^. 
An examination of the data in Table 1 will show that both the val­
ine and isoleucine chloromethyl ketones were as effective or slightly 
more effective than the standard inhibitor, Ac-Ala-Ala-Pro-Ala-CR^Cl. 
The best inhibitors of the series, Ac-Ala-Ala-Pro-Ile-CH^Cl, has a sec­
ond-order rate constant (k , -./[I]) equal to 48 M ^ sec ^ at 30.0°C and 
obsd 
pH 5.0. These limited results suggest that the primary specificity 
pocket of porcine pancreatic elastase is large enough to accommodate 
Val, lie and Ala as P^ inhibitors without fostering steric repulsion and 
perhaps even provides small hydrophobic i n t e r a c t i o n s . 
The peptide chloromethyl ketone, Ac-Ala-Ala-Pro-Thr-CR^Cl, was dis­
covered to be relatively unreactive toward porcine pancreatic elastase 
under the inhibition conditions employed here. Enzyme inactivation 
was observed to be over 400 times slower for this threonine derivative 
than for the isosteric valine inhibitor. 
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RNH-CH-C0CH oCl RNH-CH-COCH.Cl i 2. 
CH / \ CH / \ 
CH, CH. 
3 ~"3 
valine chloromethyl ketone 
CH, OH 
threonine chloromethyl ketone 
This decrease in reactivity was quite surprising and might be interpre­
ted in terras of intermolecular hydrogen-bonding between the hydroxyl 
group of the threonine chloromethyl ketone and some residue in the 
catalytic site of elastase. Such an enzyme-inhibitor interaction could 
force a rotation about the C bond of the threonine inhibitor. The 
a 
result would be a decreased rate of inactivating alkylation within the 
bound complex due to the altered conformation of the inhibitor. On the 
other hand, intramolecular inhibitor hydrogen-binding (between the B-OH 
of threonine and the C= 0 of the adjacent proline) 
• HO^ ^ CH 
*C 
f y C H j ^ C 0 C H 2 C 1 
H 
might occur. Irreversible alkylation via formation of a covalent bond 
between His-45 and this chloromethyIketone would be severely diminished, 
It is unlikely, however, that the failure of the threonine chloromethyl 
ketone to effectively inhibit elastase is a result of steric repulsion 
in the S^ subsite of the enzyme. Both valine and isoleucine deriva­
tives also have medium-sized alkyl side chains but are seen to react 
quite rapidly with elastase. 
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Effectiveness of Human Leukocyte Elastase Inhibitors 
A comparison of the peptide chloromethyl ketone inhibitors, based 
on their relative ^ 0 b S ( j ^ I ] values, leads to several interesting rela­
tionships between the structure of inhibitors and reactivity toward 
human leukocyte elastase. Two tetrapeptides, Ac-Ala-Ala-Pro-Val-CH^Cl 
and Ac-Ala-Ala-Pro-Ile-C^Cl were observed to be 40-50 times more reac­
tive than the standard inhibitor, Ac-Ala-Ala-Pro-Ala-CH 2Cl (Table II). 
This results suggests that the side chains of valine and isoleucine, 
extending about 2-4 A from C^, are better able to make van der Waals 
contact within the hydrophobic binding pocket of human elastase. 
Alanine, on the other hand, has a side chain too small (1 - 2 & from C ) 
a 
to interact significantly with the enzyme. That hydrophobic bonding is 
an important driving force for noncovalent intermolecular interactions 
in aqueous solution has been discussed by Jencks (1969). 
The threonine peptide chloromethyl ketone was again observed to 
be relatively unreactive. An explanation for this behavior with human 
leukocyte elastase is similar to that outlined for the porcine pan­
creatic enzyme. The relative reactivity of various P^ inhibitors with 
human elastase can be represented by Val, lie >> Ala > Thr. 
Comparisons of the Two Kinds of Elastase 
At this point it is of interest to examine certain inhibition char­
acteristics of human leukocyte elastase as compared to the more thor­
oughly studied porcine pancreatic elastase. The nature of such differ­
ences may provide some insight into their separate biological functions. 
For example, leukocyte elastase generally reacts slightly less rapidly 
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with the group of peptide chloromethyl ketones than does pancreatic 
elastase, as indicated by the somewhat smaller values of k , ,/[I] 
J obsd 
for inhibition (Table 5 ). This behavior is most likely due to the 
lesser specific activity of the leukocyte enzyme. More significantly, 
however, the P^ valine or isoleucine chloromethyl ketones were dra­
matically more reactive than the standard alanine tetrapeptide in the 
case of leukocyte elastase. This substantial difference in the rates 
of inhibition definitely establishes that the human leukocyte enzyme 
is distinct from the porcine pancreatic enzyme. 
Inhibition Studies with Trypsin and Chymotrypsin 
To be useful in physiological experiments, our chloromethyl 
ketones should selectively as well as effectively inactivate elastolytic 
enzymes in preference to such related serine proteases as chymotrypsin 
and trypsin. Although these proteolytic enzymes are homologous with 
elastase, they show structural differences at their primary binding 
sites to accommodate different kinds of substrate P 1 residues. Each 
enzyme possesses a pronounced pocket adjacent to the catalytic resi­
dues having special dimensions and steric and electrostatic properties. 
For example, chymotrypsin contains a hydrophobic, slot-shaped pocket and 
can easily accommodate residues with aromatic side chains, e.g. Phe, Tyr 
and Trp, as well as other large residues such as leucine. Trypsin's 
binding pocket, on the hand hand, contains an anionic carboxylate group. 
Consequently, trypsin is specific for amino acid residues with posi­
tively-charged side chains such as lysine or arginine. Because the 
binding pocket of porcine pancreatic elastase is partially crowded with 
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the alkyl group of Val-216, this enzyme is specific for residues with 
relatively small alkyl side chains. 
Table 3 presents the kinetic results for the attempted inactiva-
tion of trypsin with the four tetrapeptide chloromethyl ketones. 
These compounds were completely unreactive toward trypsin even after 
4 hours under our standard inhibition conditions. Consequently, no 
kinetic constants could be determined. Control experiments without 
inhibitor indicated, however, that the enzyme remained almost fully 
active during this time period. 
The results for the inhibition experiments with chymotrypsin are 
shown in Table 4. K , values appeared to increase as the P-
obsd r r 1 
alanine, valine and isoleucine side chain residues were made larger. 
Not surprisingly, these inhibitors were seen to inactivate chymotrypsin 
only 1 to 6 times less effectively than Boc-Gly-Leu-Phe-CI^Cl, a 
chloromethyl ketone reported to be an excellent inhibitor for 
a-chymotrypsin (Kurachi et al., 1973). As previously mentioned, chymo­
trypsin is known to show a specificity for residues possessing aro­
matic or large hydrophobic alkyl side chains. Since the reaction con­
ditions employed in these inhibition studies with chymotrypsin were 
virtually identical with those used for the human leukocyte elastase, 
a direct comparison of results is possible (refer to Table 5 ) . In 
general, those tetrapeptide inhibitors with lie, Val or Ala P^ residues 
were observed to inactivate chymotrypsin slower than either the human 
leukocyte or porcine pancreatic elastase enzymes. For example, 
Ac-Ala-Ala-Pro-Val-CH 0C1 was found to inhibit chymotrypsin with 
Table 3. Inhibition of Trypsin with Tetrapeptide Chloromethyl Ketones. a 
Inhibitor 
p p p p 4 3 r 2 *1 [I] x 1 0
4 , M Time (hr) Activity b (%) 
Ac-Ala-Ala-Pro-Ile-CH 2C1 0.5 4 88 
Ac-Ala-Ala-Pro-Val-CH 2C1 0.5 4 90 
Ac-Ala-Ala-Pro-Ala-CH 2 C1 2.0 4 87 
Ac-Ala-Ala-Pro-Thr-CH 2C1 100.0 4 89 
None° 4 89 
Trypsin concentration 10 yM, at pH 6.5, 30.0°, 5% (v/v) methanol 
^Enzyme activity after t (hr) measured as percent of initial activity at t = 0. 
Control experiment. 
Table 4. Inhibition of a-Chymotrypsin with Tetrapeptide Chloromethyl Ketones. 
Inhibitor 
A 
i n 4 ! - 1 
10 k , sec 
obsd 
Half-life, obsd 
P P P P 4 *3 2 1 [I] x 10 , M (std. dev.) min M - l -1 M sec 
(rel. values) 
Ac-Ala-Ala-Pro-Ile-CH 2Cl 0.5 3.20 (.03) 36.1 6.4 (5.8) 
Ac-Ala-Ala-Pro-Val-CH 2Cl 0.5 .98 (.03) 117.8 2.0 (1.8) 
Ac-Ala-Ala-Pro-Ala-CH 2Cl 2.0 2.27 (.06) 52.5 1.1 (1.0) 
Ac-Ala-Ala-Pro- Thr- CH 2C1 100.0 5.36 (.12) 21.5 .05 (.05) 
Boc-Gly-Leu-Phe-CH 2Cl 6.6 b (6.0) 
Chymotrypsin concentration 10 uM, at pH 6 .5, 30.0°, 5% (v/v) methanol 
bValue adjusted to pH 6.5 from measurement at pH 5.0 (Kurachi et al., 1973) assuming K^ K o^/[I] at 
pH 5.0 would be ca 20% of k o b s d / [ I ] a t P R 6.5. 
Table 5. Inhibition of Chymotrypsin and Elastase with Tetrapeptide 
Chloromethyl Ketones. 3 
Inhibitor Chymotrypsin Leukocyte Elastase Porcine Elastase 
P 4 P 3 P 2 P x k o b s d / t I ] k o b s d / [ I ] k o b s d / [ I ] k o b s d / [ 1 1 k o b s d / [ I ] k o b s d / ( I ] 
( M - 1 sec" 1) (rel) C ( M - 1 sec" 1) (rel) c ( M _ 1 sec" 1) (rel) c 
Ac-Ala-Ala-Pro-Val-CH 2C1 2.0 1.8 160 150 175 160 
Ac-Ala-Ala-Pro-Ile-CH 2Cl 6.4 5.8 133 120 240 220 
Ac-Ala-Ala-Pro-Ala-CH 2Cl 1.1 1.0 3.4 3.1 200 180 
Ac-Ala-Ala-Pro-Thr-CH 2C1 .05 .04 .15 .04 .4 .002 
aElastase concentration 5-10 yM, inhibitor concentration 0.05-10.0 mM, 5% (v/v) methanol, 
at 30.0° and pH 6.5. 
^These values were calculated for pH 6.5 assuming that k , J / C 1 ] values measured at pH 5.0 would 
be ca 20% of k /[I] values at pH 6.5 (Powers and Tuhy, 1973). 
c 
These three sets of results are on an identical scale. 
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k , = 2.0 M sec and half-life = 118 minutes. However, this obsd 
inhibition rate was only about 1% of that observed with the leukocyte 
elastase. Even the isoleucine chloromethyl ketone, with its somewhat 
extended alkyl side chain, inhibited chymotrypsin at a rate less than 
5% of that observed with the human leukocyte elastase under identical 
conditions. 
Significance of Results 
Peptide chloromethyl ketones have proved useful for studies of 
human leukocyte elastase and its biological activity. For example, 
Dr. Aaron Janoff has shown that chloromethyl ketones inhibit the diges­
tion of elastin-rich human lung tissue and rat aortic tissue by a human 
granulocyte elastase in vitro (Janoff, 1972a). A number of further 
studies using chloroketone inhibitors are currently in progress. 
Our results suggest that peptide chloromethyl ketones, if properly 
designed, can be made fairly specific for human leukocyte elastase. 
Such specificity is necessary if chloromethyl ketone inhibitors are to 
be utilized safely in the treatment of emphysema and related diseases. 
Side reaction interference with other critical biological functions is 




In conclusion, the kinetic results indicate that P^-valine, 
isoleucine and alanine tetrapeptide chloromethyl ketones are reactive 
and specific inhibitors for both porcine pancreatic elastase and 
human leukocyte elastase. The analogous threonine chloromethyl ketone 
was relatively unreactive, presumably due to hydrogen-bonding induced 
conformational changes. These tetrapeptide inhibitors were also shown 
to be fairly specific for elastolytic enzymes in preference to trypsin 
or chymotrypsin. With porcine pancreatic elastase, both the valine and 
isoleucine chloromethyl ketone inhibitors were as effective or slightly 
more effective than our standard alanine inhibitor. With human leukocyte 
elastase, however, the valine and isoleucine inhibitors were markedly 
more effective than the alanine inhibitor (the best one being Ac-Ala-Ala-
Pro-Val-C^Cl). This result implies that these two elastolytic enzymes 
are different and distinct. 
Human leukocyte elastase has recently been implicated in the 
pathology of emphysema and related inflammatory diseases. Eventually 
chloromethyl ketone inhibitors may become valuable in the treatment of 




The anomalous kinetic behavior of Ac-Ala-Ala-Pro-Thr-C^Cl with 
elastase reported herein might form the basis for further chemical 
inquiry. A profitable extension of our work would be to mask the 
hydroxyl group of the threonine amino acid residue by O-methylation 
and investigate the reactivity of this new chloromethyl ketone with 
elastase. This derivative, approximately isosteric with the very reac­
tive isoleucine inhibitor, should be easily accommodated within the 
primary binding pocket of elastase. A comparison with the relatively 
ineffective parent inhibitor, therefore, would be meaningful. A rapid 
rate of inactivation would affirm previous interpretations of the 
ineffective kinetic behavior of the parent threonine-P^ inhibitor. A 
slow rate of inactivation by the masked chloromethyl ketone, however, 
would not eliminate the possibility that the oxygen of either threonine 
inhibitor was hydrogen-bonded to some enzyme hydrogen-donor. 
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